Mass spectrometric studies on peptides and proteins : conformations of Escherichia coli Thioredoxin and its alkylated adducts studied by hydrogen/deuterium exchange and HPLC-electrospray ionization mass spectrometry by Deinzer, Max L. et al.
AN ABSTRACT OF THE THESIS OF
Moo-young Kim for the degree of Doctor of Philosophy in Chemistry presented
on December 13, 2000. Title: Mass Spectrometric Studies on Peptides and
Proteins: Conformations of Escherichia coli Thioredoxin andItsAlkylated
Adducts Studied by Hydrogen/Deuterium Exchange and HPLC-Electrospray
Ionization Mass Spectrometry.
Abstract approved.
Redacted for Privacy
Max L. Deinzer
E. coli thioredoxin (TRX) was modified by the episulfonium ion derived
from S-(2-chloroethyl)glutathione (CEG) or S-(2-chloroethyl)cysteine (CEC). The
alkylation site was located at Cys-32, which was confirmed by tandem mass
spectrometry. Two forms of native TRX, Oxi- and Red-TRX, and two modified
TRXs, GS- and Cys-TRX, were examined by hydrogen/deuterium(H/D)
exchange reactions using electrospray ionization mass spectrometry (ESI-MS)
for the analysis.
Conformational dynamics during thermal denaturation were probed by H/D
exchange-in experiments. Under conditions in which the folded conformational
state is marginally stable, H/D exchange-in experiments resulted in mass spectra
differing in the number of incorporated deuteriums which indicates the presence
of two distinct populations of molecules. As the exchange-in time increased, the
population representing the unfolded state increased and the population for the
folded state decreased. The rate of conversion was used to estimate the rateconstant of unfolding. ESI mass spectra were also recorded as a function of
temperature without H/D exchange, and the observed bimodal charge state
distributions were analyzed in order to estimate melting temperatures. GS-TRX
showed increased resistance to hydrogen isotope exchange in comparison with
Red-TRX indicating that there were enhanced intramolecular interactions in the
former protein.
Pepsin digestion was performed on deuterated TRXs to analyze different
structural regions. The amount of deuterium incorporated was monitored with
peptic peptides from deuterated TRXs with different exchange-in incubation
periods. Deuterium levels of each peptide were plotted versus the exchange time
and fitted with a series of first-order rate terms. The regions 59-80 and 81-108 of
Oxi- and Red-TRX showed an EX1 mechanism as evidenced by two distinct
mass envelopes that appeared after a short incubation time in deuterated
solvent.
Tandem mass spectrometry (MS/MS) was carried out to obtain the
information on individual amide linkages. MS/MS data showed generally
excellent correlations with the exchange rate constants from published NMR data
on Oxi- and Red-TRXs. Two residues, Ile-75 and Ala-93 in GS-TRX indicated the
most probable sitesresponsible for induced H-bonding by the attached
glutathionyl group, which was consistent with the energy minimized structure
predicted by AMBER force field constants.C Copyrightby Moo-young Kim
December 13, 2000
All Rights ReservedMass Spectrometric Studies on Peptides and Proteins:
Conformations ofEscherichia coliThioredoxin and Its
Alkylated Adducts Studied by Hydrogen/Deuterium Exchange and
HPLC-Electrospray Ionization Mass Spectrometry
by
Moo-young Kim
A THESIS
submitted to
Oregon State University
in partial fulfillment of
the requirements for the
degree of
Doctor of Philosophy
Completed December 13, 2000
Commencement June 2001Doctor of Philosophy thesis of Moo-young Kim presented on December 13, 2000
APPROVED:
Redacted for Privacy
Major Professor, Chemistry
n
Redacted for Privacy
Chair, DepartmentChemistry
Redacted for Privacy
Dean of Graduate Sct4I
Iunderstand that my thesis will become part of the permanent collection of
Oregon State University libraries. My signature below authorizes the release of
my thesis to any reader upon request.
Re'clacted for Privacy
Moo-young Kim, AuthorACKNOWLEDGMENTS
I thank Dr. Max Deinzer for his guidance, support, and example, and for
the opportunity to pursue mass spectrometric studies on proteins.I thank Dr.
Claudia Maier and Dr. Xuguang Yan for their enthusiasm,advice, and
encouragement.Ithank my committee members, Dr. Don Reed, Dr. Kevin
Gable, Dr. Victor Hsu, Dr. Douglas Barofsky, and Dr. Goran Zovanovic for their
willingness and critical evaluation of my thesis. I would especially like to thank Dr
P. Shing Ho for his efforts for the energy-minimized protein structure.
I would also like thank Don Griffin and Brian Arbogast for their consistent
and patient support in mass spectrometry and HPLC experiments. I also value
the friendships of Dr. Susan Chen, Lilo Barofsky, and Alan Taylor.Ithank
Jeannine Lawrence for the technical advice related to circular dichroism. I thank
fellow students Dr. Philip Gafken, Dr. Paul Mazurkiewicz, Heidi Zhang, April
Mixon, Sunghwan Kim, Catalin Doneau, and Melissa Shultz for their help and
friendship.
I owe very special thanks to my parents for my up-bringing and teaching
me to have a Christian faith.I am also thankful to my son, Seokwon, for his
radiant smile, my nephew, Myunghoon, for his unexpected questions and my
sister, Heeyoung, for her long distance love.
My sincere apologies to the many other people not mentioned here who
also deserve my thanks.TABLE OF CONTENTS
Page
Chapter 1 Background 1
1.1 Protein folding 1
1.2 Hydrogen exchange mechanism 5
1.3 Thioredoxin 15
1.4 Electrospray ionization mass spectrometry 18
Chapter 2 Results and Discussion 27
2.1 Alkylation of E. coli thioredoxin and identification of the adducts 27
2.1-1 Synthesis of alkylating agents 28
2.1-2 Reduction and alkylation of E. coil thioredoxin by
CEG and CEC 28
2.1-3 Identification of modified sites in the alkylated TRXs
by ESI-MS/MS 31
2.1-4 Sample pretreatment of purified modified TRXs 36
2.2 Thermal denaturation of E. coil thioredoxin and its derivatives 39
2.2-1 Online H/D exchange and ESI-MS experiments 39
2.2-2 Offline H/D exchange and ESI-MS experiments 53
2.2-3 Analyses of bimodal charge state distributions 55
2.2-4 Spectroscopic experiments : UV absorption and
circular dichroism 59
2.3 Structural features of TRXs analyzed by H/D exchange 64
2.3-1 Peptide mapping and sequencing of thioredoxins 64
2.3-2 H/D exchange of TRXs, proteolysis, and the
determination of deuterium content of peptide segments70
2.3-3 H/D exchange of TRXs, proteolysis, and tandemmass
spectrometry for residue-specific hydrogen exchange 89
2.3-4 Energy-minimized structure of GS-TRX 120
2.4 Conclusion 122
Chapter 3 Experimental 125
3.1 Alkylation of E. coil thioredoxin and identification of the adducts127
3.1-1 Synthesis of alkylating agents 127TABLE OF CONTENTS (CONTINUED)
Page
3.1-2 Reduction and alkylation of E. coli thioredoxin by
CEG and CEC 128
3.1-3 Identification of modified sites in the alkylated TRXs
by ESI-MS/MS 129
3.1-4 Sample pretreatment of LC-purified modified TRXs 131
3.2 Thermal denaturation of E. coli thioredoxin and its derivatives 132
3.2-1 Online H/D exchange and ESI-MS experiments 132
3.2-2 Offline H/D exchange and ESI-MS experiments 136
3.2-3 Analyses of bimodal charge state distributions 141
3.2-4 Spectroscopic experiments : UV absorption,
Circular dichroism 142
3.3 Structural features of TRXs analyzed by H/D exchange 144
3.3-1 Peptide mapping and sequencing of TRXs 144
3.3-2 H/D exchange of TRXs, proteolysis, and the
determination of deuterium content of peptide segments 146
3.3-3 H/D exchange of TRXs, proteolysis, and tandem mass
spectrometry for residue-specific hydrogen exchange 152
3.3-4 Structural calculations of GS-TRX 152
References 157LIST OF FIGURES
Figure Page
1.1Hydrogen exchange rate constants of amide hydrogens and side
chain hydrogens 6
1.2Identification of the secondary structures in proteins by HID exchange
and mass spectrometry 8
1.3Pictorial representation of the hydrogen exchange mechanism from
folded and unfolded proteins 10
1.4Experimental procedure for continuous and pulsed deuterium labeling
14
1.5Electron transport sequences by thioredoxin system 16
1.6NMR solution structure and sequence of oxidized E. coli thioredoxin 17
1.7Electrospray ionization mechanism 19
1.8Sample introduction methods and mass analyzers for ESI 20
1.9Schematic diagram of tandem mass spectrometry 22
1.10Fragment ions obtained from cleavage of a peptide backbone 23
1.11Mechanisms for the formation of b and y ions 25
2.1Electron transport sequences by the glutathione system 27
2.2ASyntheses of alkylating agents 29
2.2BAlkylation of E. coli thioredoxin by CEG and CEC 29
2.3Total ion chromatogram of the reaction mixture of GS-TRX 30
2.4ESI mass spectrum of the alkylated T3 fragment of GS-TRX 32
2.5ESI mass spectrum of a peptide 28-39 of GS-TRX and CIDspectrum
of the 2+ charged ion (m/z 772.4) of peptide 28-39 34
2.6ESI mass spectrum of a peptide 28-39 of Cys-TRX and CIDspectrum
of the 2+ charged ion (m/z 680.0) of peptide 28-39 35
2.7ESI mass spectra of HPLC-purified GS-TRX in 1% acetic acidat
different temperatures: (A) 54 °C, (B) 45 °C, and (C) 25 °C 37LIST OF FIGURES (CONTINUED)
Figure Page
2.8Temperature dependent variation of F/(F+U) for GS-TRX before and
after 45 °C equilibration 38
2.9Instrumentation for on-line H/D exchange-in experiments 40
2.10Total ion chromatogram of H/D exchanged Oxi-TRX 42
2.11Charge state distribution of Oxi-TRX in 1% acetic acid 42
2.12Temperature dependent alteration of the exchange mechanism 44
2.13Evolution of the 8-fold charged ion peaks of TRXs 45
2.14A 8-Fold charged ion peak of Red-TRX and its fitting with four
Gaussian functions 47
2.14B 8-Fold charged ion peak of Red-, GS-, and Cys-TRX and their
fitting with Gaussian functions 48
2.15A Change in the fraction of folded conformers at 50 °C with time 49
2.15B Change in the fraction of folded conformers at 55 °C with time 50
2.15C Change in the fraction of folded conformers at 60 °C with time 51
2.16Experimental setup for offline H/D exchange-in 53
2.17H/D exchange time courses for TRXs in 1% AcOD/D20 at 22 °C 54
2.18ESI mass spectra of Oxi-TRX in 1% acetic acid at different
temperatures: (A) 85 °C, (B) 65 °C, and (C) 25 °C 56
2.19Denaturation curves of TRXs in 1% acetic acid 58
2.20 UV spectra of TRXs 59
2.21Near UV CD spectra of TRXs 61
2.22Near UV CD spectra of thermal denaturation of Oxi-TRX 61
2.23Denaturation curves from the analyses of near UV CD spectra 62
2.24Far UV CD spectra of TRXs 62LIST OF FIGURES (CONTINUED)
Figure
Total ion chromatograms of peptides produced from the peptic
Page
2.25
digestion of TRXs 65
2.26Instrumentation (HPLC-MS) for peptide mapping and sequencing
of pepsin digests of TRXs 67
2.27Peptic peptide identification 68
2.28Peptides identified in the peptic digests of TRXs by MS/MS 69
2.29Diagram of the general procedure used to determine the deuterium
content of the peptic peptides in H/D exchanged TRXs 71
2.30ESI mass spectra of the doubly charged molecular ions of fragment
28-39 and the triply charged molecular ions of fragment 59-80 73
2.31Deuterium levels found in peptic segments of Oxi-TR 77
2.32Deuterium levels found in peptic segments of Red-TRX 78
2.33Deuterium levels found in peptic segments of GS-TRX 79
2.34Deuterium levels found in peptic segments of Cys-TRX 80
2.35Distribution of amide hydrogen exchange rates in peptic fragments
of TRXs 83
2.36Molecular ion peaks of peptic peptides 59-80 and 81-101 of Oxi-
and Red-TRX during H/D exchange-in experiments 86
2.37Estimation of the rate constant,k1,of peptic peptides 59-80 and
81-101 of Oxi- and Red-TRX 87
2.38Strategy for the determination of deuterium levels at individual
peptide amide linkages 90
2.39Molecular weight calculation of b and y ions 91
2.40CID MS/MS of singly and doubly charged precursor ions of a
peptic peptide 1-12 of 20s labeled Oxi-TRX 93
2.41CID MS/MS spectra of peptide 1-24 of Oxi-TRX 94LIST OF FIGURES (CONTINUED)
Figure Page
2.42Overlapped isotopic multiplets of b12 and y13 ions derived from
CID MS/MS spectra of peptic peptide 1-24 of 20s labeled Oxi-TRX 95
2.43Comparison of b ions and y ions in the deuterium levels on peptide
amide linkages in peptide 1-24 of Oxi-TRX 99
2.44Deuterium levels found at peptide amide linkages in fragment 1-24
of Oxi-, Red- and GS-TRX 103
2.45 NMR solution structure of Oxi-TRX highlighted in fragment 1-24 103
2.46A Expected CID fragmentation of peptides 28-39 and 28-37 104
2.46B CID MS/MS spectra of peptide 28-39 (Oxi-TRX) and 28-37
(Red-, GS-, Cys-TRX) of 20s labeled TRXs 105
2.47Schematic representation of the glutathionyl group in the energy
minimized geometry calculated for GS-TRX 108
2.48 NMR solution structure of Oxi-TRX highlighted in fragment 45-58 110
2.49 NMR solution structure of Oxi-TRX highlighted in fragment 59-80 113
2.50Calculated energy-minimized structures of GS-TRX 115
2.51Schematic representation showing interactions between the
adducted glutathionyl group and TRX 116
2.52 NMR solution structure of Oxi-TRX highlighted in fragment 81-108 117
2.53The deuterium levels on peptide amide linkages and H/D exchange
rate constants of Oxi- and Red-TRX 119LIST OF TABLES
Table Page
2.1Conversion rate constants of TRXs in 1% acetic acid solution 52
2.2Estimation of secondary structural elements of TRXs based on far UV
CD spectra and singular value decomposition 63
2.3Summary of EX1 and EX2 kinetics of peptic peptides obtained from
H/D exchange-in experiments of TRXs in 1% AcOD/D20 74
2.4Numbers of amide hydrogens that have exchanged with H/D exchange
rate constants (rate groups) for common peptides from TRXs 81
2.5Deuterium levels found at individual amide linkages in peptide 1-24 of
Oxi-TRX as determined by CID MS/MS 97
2.6Deuterium levels found at individual amide linkages in peptide 1-24 of
Oxi-, Red-, and GS-TRX 102
2.7The m/z values found in the CID spectra for peptides 28-39 or 28-37
106
2.8Deuterium levels found at individual amide linkages in peptides 28-39
and 28-37 107
2.8Deuterium levels found at individual amide linkages in peptide 45-58
2.10Deuterium levels found at individual amide
and 59-80
2.11Deuterium levels found at individual amide
81-108
3.1CID fragment ions of peptic peptide 28-39 of GS-TRX
3.2CID fragment ions of peptic peptide 28-37 of Cys-TRX
3.3Temperature dependent variation of F/(F+U) for GS-TRX before and
after 45 °C equilibration
3.4Time-dependent changes of bimodal 8-fold charged molecular ion
peak of TRXs in 1% AcOD/D20 at 50 °C
linkages in peptides 59-79
linkages in peptides
110
112
114
130
131
131
133LIST OF TABLES (CONTINUED)
Table Page
3.5Time-dependent changes of bimodal 8-fold charged molecular ion
peak of TRXs in 1% AcOD/D20 at 55 °C 134
3.6Time-dependent changes of bimodal 8-fold charged molecular ion
peak of TRXs in 1% AcOD/D20 at 60 °C 135
3.7Percent deuterium incorporation on Oxi-TRX after exchange-in
in 1% AcOD/D20 at 25 °C 137
3.8Percent deuterium incorporation on Red-TRX after exchange-in
in 1% AcOD/D20 at 25 °C 138
3.9Percent deuterium incorporation on GS-TRX after exchange-in
in 1% AcOD/D20 at 25 °C 139
3.10Percent deuterium incorporation on Cys-TRX after exchange-in
in 1% AcOD/D20 at 25 °C 140
3.11Temperature dependent variation of F/(F+U) of TRXs 141
3.12Temperature dependent variation of the mean residue molar
ellipticity at 280 nm, [O]2m of TRXs in 1% AcOH/H20 143
3.13Observed fragment ions in CID MS/MS spectra of peptic peptides
from the digestion of TRXs 144
3.14Deuterium levels of peptic peptides from Oxi-TRX in H/D
exchange-in experiments in 1% AcOD/D20 147
3.15Deuterium levels of peptic peptides from Red-TRX in H/D
exchange-in experiments in 1% AcOD/D20 148
3.16Deuterium levels of peptic peptides from GS-TRX in H/D exchange-in
experiments in 1% AcOD/D20 149
3.17Deuterium levels of peptic peptides from Cys-TRX in H/D exchange-in
experiments in 1% AcOD/D20 150
3.18CID fragment ions of peptic peptide 1-24 of TRXs afteran incubation
in 10 mM phosphate buffer (D20, pD 5.7) for 20sec 154LIST OF TABLES (CONTINUED)
Table Page
3.19CID fragment ions of peptic peptide 28-39 or 28-37 of TRXs after
an incubation in 10 mM phosphate buffer (D20, pD 5.7) for 20 sec 154
3.20CID fragment ions of peptic peptide 45-58 of TRXs after an incubation
in 10 mM phosphate buffer (D20, pD 5.7) for 20 sec 155
3.21CID fragment ions of peptic peptide 59-79 or 59-80 of TRXs after an
incubation in 10 mM phosphate buffer (D20, pD 5.7) for 20 sec 155
3.22CID fragment ions of peptic peptide 81-101 or 81-108 of TRXs after
an incubation in 10 mM phosphate buffer (D20, pD 5.7) for 20 sec 156LIST OF EQUATIONS
Equation Page
(1)Rate constant for hydrogen isotope exchange, kex 5
(2)Temperature dependence of kex 7
(3)Hydrogen exchange rate constant for the unfolded proteins 11
(4)H/D exchange rate constant for the EX2 mechanism 12
(5)H/D exchange rate constant for the EX1 mechanism 13
(6)H/D exchange rate constant for normally folded proteins 14
(7)Percent of deuterium incorporation 55
(8)Adjustment of measured deuterium levels 75
(9)Expression for the exchange rate constant, ki 76
(10)Four-component nonlinear regression expression for exchange rate
constant 76
(11)Molecular weight calculation of a charged ion 91
(12)Adjustment of the number of deuteriums incorporated in amide
linkages 96
(13)The mean residue molar ellipticity 142ABBREVIATIONS
CD, circular dichroism
CEC, S-(2-chloroethyl)cysteine
CEG, S-(2-chloroethyl)glutathione
CID, collisionally induced dissociation
ESI, electrospray ionization
FTMS, fourier transform mass spectrometry
H/D, hydrogen/deuterium
HPLC, high performance liquid chromatography
MALDI, matrix assisted laser desorption ionization
MS, mass spectrometry
MS/MS, tandem mass spectrometry
NADPH, nicotinamide adenine dinucleotide phosphate, reduced
NMR, nuclear magnetic resonance
SORI, sustained off-resonance irradiation
TR, thioredoxin reductase
TCEP, tris(2-carboxyethyl)phosphine
TRX, Escherichia coil thioredoxin
Oxi-TRX, oxidized Escherichia cofi thioredoxin
Red-TRX, reduced Escherichia coil thioredoxin
GS-TRX, glutathionyl Escherichia coil thioredoxin
Cys-TRX, cysteinyl Escherichia coil thioredoxin
UV, ultravioletDEDICATION
I dedicate this thesis to my wife, Anna. I am eternally grateful for her love,
encouragement, friendship, and support."You did not choose Me, but I chose you and
appointed you that you should go and bear
fruit, fruit that shall last." John 15:16Mass Spectrometric Studies on Peptides and Proteins:
Conformations of Escherichia coil Thioredoxin and Its
Alkylated Adducts Studied by Hydrogen/Deuterium Exchange
and HPLC-Electrospray Ionization Mass Spectrometry
CHAPTER 1
BACKGROUND
1.1 Protein folding
Proteins are responsible for many of the chemical and physical
processes that support life. These molecules are ubiquitous inallliving
creatures. Proteins are linear polymers consisting of amino acids. They have
four levels of structural organization: primary (sequence), secondary (local
folding), tertiary (overall folding), and quaternary (multichain association). To
function, it is necessary for polypeptide chains to fold into the unique native
three-dimensional structure that is characteristic for each protein. The three-
dimensional structures of folded proteins results from a combination ofnon-
covalent interactions including short-range repulsion, electrostatic forces,van
der Waals interactions, and hydrogen bonding.
Proteinfolding problems are among the most fundamental and
challenging problems in the life sciences. Localized as wellas global structural
changes often accompany protein functions such as catalysis and electronor
oxygen transport. Characterization of these structural changes in terms of
atomiclocations, thermodynamics and dynamicsisthebasisfor our
understanding of how a protein performs its function. From a practical point of
view, a knowledge of how a protein folds may be key to understandingmany of2
the events involved in cellular regulation, the causes of certain cancers and
geneticdiseases,andultimatelytheinformationnecessarytofind
corresponding therapeutic treatments.
The folded conformations of proteins are only marginally stable under
the best of conditions and can often be disrupted by environmental factors,
such as a rise in temperature, variation in pH, increase in pressure, or the
addition of denaturants. The protein is then said to be denatured. Denaturation,
when it clearly involves protein unfolding, need not involve changes in covalent
structure and, therefore, is almost always reversible. In some cases, proteins
can be unfolded by (a) breaking disulfide bonds present, (b) removing essential
cofactors, (c) mutating certain crucial residues, or (d) deleting residues from the
primary structure.
The conformations of proteins are categorized into three different states:
native state, unfolded state, and molten globule state. The native states of
proteins are well packed, with an optimal reductioninsolvent exposed
hydrophobic surface areas and all hydrogen bonding groups have either
additional protein groups or solvents as partners. The molten globule statesare
protein conformations that are neither fully folded nor fully unfolded. The
general consensus of the condition of this state is that it is compact and hasa
sizable hydrophobic core; it has a high content of secondary structure and
native-like tertiary fold; while at the same time it has significant structural
flexibility with mostly nonspecific tertiary interactions.1 Unlike the structures of
native states, the structures of unfolded or denatured states of proteinsare
much less well understood because so many conformationsare possible.
Information about secondary structures of proteinscan be obtained by
circular dichroism (CD).2 The proportion of a-helix and n -sheet structurescan
be determined by this method. However, CD does not reveal the specific3
locationofa-helicalorn-sheetstructureswithintheprotein.X-ray
crystallography determines the tertiary and quaternary structures of proteins.3
At the highest resolution, X-ray diffraction can be used to assign the three-
dimensional location of every atom in a protein crystal. Spectrophotometry is
used to determine the absorption of ultraviolet and visible light by proteins.4
The amino acids tryptophan, tyrosine, and phenylalanine all have useful
absorptionspectra, and measuring their absorptions withlightat 280
nanometers (nm) wavelengthisa simple way ofdeterminingprotein
concentration.Nuclear magnetic resonance (NMR) has been used for
determining the tertiary structures of peptides and small proteins.5
Mass spectrometry (MS) gives highly accurate determinations of protein
molecular mass. Electrospray ionization (ESI)6 and matrix-assisted laser
desorption ionization (MALDI) MS7 have provided a breakthrough to analyzing
macromolecules larger than 100 kDa. Whereas these methods have been
successfully applied to determine the molecular weight and primary structure of
biopolymers, the recently developed methodology for direct characterization by
ESI-MS of complexes containingnoncovalentinteractions,opens new
perspectives for supramolecular chemistry and analytical biochemistry.
Hydrogen/deuterium (H/D) exchange measurements are important in
studies of the dynamics of protein molecules and their folding behavior.8 Amide
hydrogen exchange rates appear to depend on whether the hydrogens are
participating in intramolecular hydrogen bonding, as well as on the extent to
which the hydrogens are shielded from the solvent. Hydrogen exchange has
proved useful for studies of proteins for which the structures of two functionally
different states are similar, while their stabilities and hydrogen exchange rates
are substantially different.9 Such differences in hydrogen exchange behavior
suggest that hydrogen exchange may be an important source of information4
about the dynamic processes proteins undergo. Hydrogen exchange has also
proved useful for identifying intermediates formed during protein folding and
unfoldingl° and in studies of protein-protein complexation."
The principal advantages of hydrogen exchange by MS are the small
concentrations of protein required, the lack of a requirement for completely
purified proteins, and the ability to perform time resolved studies over a very
broad dynamic range. NMR methods retain the advantage of atomic resolution,
but MS methods are moving rapidly in that direction. MS is unique in its ability
todistinguishpopulations withdifferinghydrogen exchange properties,
whereas NMR can only yield a population average of proton occupancy. This
feature has made it possible to probe the multiplicity of folding pathways and
the energy landscape of protein conformations.10c
Recent advances have been made to enhance the ability of MS to
localize sites of exchange by using proteolysis under conditions where further
exchangeisminimized.12Site-specificinformation can be obtained by
quenching the isotope exchange after a certain time. These experiments are
performed by dropping the solution pH and temperature, and digesting the
partly H/D exchanged protein with pepsin. Pepsin is used to fragment the
protein into peptides because it has maximum activity in the pH range 2-3,
where amide hydrogen exchange is slowest. Even at 0 °C, pepsin has
substantial proteolytic activity, thereby further allowing the analytical procedure
to be carried out under minimal hydrogen exchange condition. In addition,
pepsin usually cleaves at many points to give small peptides, which are a
convenient size for analysis by ESI-MS. Small peptides consisting of only a few
residues are desirable because they more accurately define the regions of the
protein that have undergone isotopic exchange. The deuterium content of each
peptic fragment can then be measured directly by ESI-MS. One limitation of the5
method is the back-exchange that inevitably occurs during purification and
subsequent analysis of the fragments. As we have seen, however, back
exchange can be minimized by performing work-up experiments at low pH, low
temperature and quickly, this method has proved useful for probing the
dynamic nature of proteins.
1.2 Hydrogen exchange mechanism
Hydrogen exchange is extremely sensitive to protein conformational
changes because exchange is effectively irreversible and cumulative. The
hydrogen exchange half times of labile protons in native proteins vary over 8-
10 orders of magnitude, from less than a second to more than a year, under
physiological conditions. The most rapidly exchanging protons have rates
similar to rates of small peptides, and presumably constitute sites freely
accessible to solvent on the protein surface.
Isotopic exchange of peptide amide hydrogens is catalyzed by acid and
base. Hence, the rate constant for HX, kex can be expressed as the sum of two
terms, as indicated in the equation
kex = kH [H +] + koH [OH-] (1)
where kH and koH are the rate constants for acid- and base-catalyzed
exchange, respectively. For polyalanine model compounds, it was found that kH
and koH usually have values of 11.3 and 2.32 x 109 M-1min-1, respectively, at
278°K and low concentrations of salts.13 The isotopic exchange rate constants,
kex, for amide hydrogens of polyalanine and side chain hydrogens of some
amino acids are given as a function of pH (Figure 1.1).a-COOH
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Figure 1.1. Hydrogen exchange rate constants for freely exposed amide
hydrogens in polyalanine and in the side chains of dipeptide models for some
amino acids. Results for Arg, Asn, Gln, Trp, and polyalanine were calculated
using eq (1) and values of kH and koH (278°K) given in the text.13b Results for
cc-COOH, oc-NH2, Ser, and Thr were obtained from model groups.14
At the minimum exchange rates for amide hydrogens between pH 2 and
3, the exchange rates of side chain hydrogens are much faster than for the
amide hydrogens. The high pH sensitivity of isotopic exchange rates dictates
careful control of pH in all hydrogen exchange experiments. In addition to their7
pH sensitivity, exchange rates of amide hydrogens are affected by adjacent
amino acid side-chains. The sensitivity to neighboring side-chains has been
quantitatively assessed using model dipeptides of the naturally occurring amino
acids. Both inductive and steric effects appear to influence amide hydrogen
exchange rates. The effects of neighboring side-chains are generally additive,
thereby forming the basis for estimating the amide hydrogen exchange rates in
peptides of any amino acid sequence as a function of pH.13b
To predict hydrogen exchange rates at other temperatures, each rate
constant obtained at 293 °K can be modified according to eq (2) in which the
activation energies for kH and koH are 14 and 17 kcal/mol, respectively.13b For
instance, decreasing the temperature from 20 to 0 °C lowers the exchange rate
approximately tenfold.
Ea
kex(T)=ke,(293) exp R T 293 (2)
Althoughside-chaineffectsinpeptidesofdifferent amino acid
sequences alter the amide hydrogen exchange rates by as much as tenfold,
secondary and tertiary structural features of folded proteinsmay decrease
amide hydrogen exchange rates as much as 108. It is this large reduction in
isotopic exchange rates that facilitates use of amide hydrogen exchangeas a
sensitive probe for detecting and locating conformational changes in proteins
(Figure 1.2). Isotopic exchange occurs while the folded protein is incubatedin
D20 buffered to the desired pD. Almost all exchangeable hydrogensexcept
those participating in hydrogen bonds or being shielded from solventare
displaced with deuterium. Following the deuterium exchange-in step, isotopic
exchange at peptide amide linkages is quenched by decreasing the pDto 2.58
and the temperature to 0 °C. If isotopic exchange was performed using typical
conditions of neutral pH at 25 °C, decreasing the pH and temperature for
isotopic quench conditions would decrease the amide hydrogen exchange rate
in an unfolded polypeptide by -105 (Figure 1.1 and eq (2)).
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Figure 1.2. Identification of the secondary structures in protein by H/D
Exchange and mass spectrometry
To determine isotopic exchange rates within small, defined regions ofa
protein, the acid protease, pepsin,is used to fragment the protein into
peptides. The peptic digest is analyzed by HPLC-MSor HPLC-MS/MS to9
determine the deuterium levels of the peptic fragments or the individual peptide
amide linkages. Of course, isotopic quench conditions must be maintained
during digestion and HPLC separation. Since a protiated mobile phase is used
for HPLC, deuterium located at rapidly exchanging sites, such as on the side-
chains or on the N- and C-termini of the peptides, are replaced with hydrogens.
Hence, the increment in molecular mass is due to deuterium located at peptide
amide linkages.
Following incubation of a folded polypeptide in D20, one may find an
increased level of deuterium at peptide amide linkages. The time dependence
of the deuterium level can be translated into a phenomenological isotopic
exchange rate constant,kex. For the simplest interpretation of hydrogen
exchange results, finding different exchange rates for different samples or
forms of a proteinis evidence that the proteinis presentindifferent
conformations.
Variouskinetic models have been developed to describe amide
hydrogen exchange in folded proteins. Most of the results for amide hydrogen
exchange in folded proteins can be explained through a two-process model
(Figure 1.3). The rate constant for isotopic exchange from the folded protein is
designated as kf = 0 k2 where p is the probability for exchange from folded form
(afunctionofseveralparameters,includingsolventaccessibility and
intramolecular hydrogen bonding), and k2 is the rate constant for hydrogen
exchange at each amide linkage in an unstructured peptide, a value that can
be calculated.13b Hydrogen exchange directly from the folded proteinis
expected to dominate for amide hydrogens located on peptide linkages near
the surface or open channels within a folded protein. Amide hydrogens that are
involved in intramolecular hydrogen bonding, e.g. in a-helices or 0-sheets, are
unlikely to undergo isotopic exchange directly from the folded protein.Hydrogen exchnage in proteins
kex = kf+ ku
Hydrogen exchange from folded proteins
D20
kf
Hydrogen exchange from unfolded proteins
CSV
EX2 kinetics
ku= K k2
EX1 kinetics
k =k1
D20 + OD"
k2
kf = fq k2
10
Figure 1.3. Pictorial representation of hydrogen exchange mechanism from
folded and unfolded proteins. The hydrogen exchange rate constants from
folded and unfolded proteins are described by kf and ku. The kinetics of the
unfolding and refolding processes are described by rate constants lc/ and k-1,
respectively, and exchange from unstructured protein backbone is described by
k2.11
A competing process, described by kw allows for a rapid unfolding and
refolding of small regions (localized unfolding), as well as the entire protein
(global unfolding). Rate constants for unfolding and refolding are designated by
k1 and 1(4, respectively. According to this model, isotopic exchange can occur
only after unfolding, which breaks intramolecular hydrogen bonds, exposing
amide hydrogens to the deuterated solvent. Hydrogen exchange involving
protein unfolding is especially important because it provides a direct measure
of the rates of protein unfolding and refolding (k1 and k.1), as well as a link to
the free energy change accompanying protein folding. From the steady state
approximation, the rate constant for the hydrogen exchange can be described
by the following eq (3).
kex
+ k2
k1k2
(3)
For most proteins at neutral pH and in the absence of denaturants, the
interconversion between the native and denatured states is rapid compared
with the exchange rates of amides in the denatured state, i.e. k..1 » k2. Under
these conditions, local refolding can occur in less than a microsecond and even
global unfolding reactions may take place within 50 ms.15 Then, the proton
occupancy at each amide linkage is uniform over all the protein populations.
The phenomenological rate constant for this second-order reaction mechanism
(EX2) is given by
kex = (kW k_i)k2 = Kk2 (4)
where K is the equilibrium constant describing the unfolding process and k2 is
the exchange rate constant for the amide hydrogen in an unstructured peptide.12
The EX2 mechanism would yield a single peak in the mass spectrum, gradually
increasing in mass over time for the exchange of a protiated protein dissolved
in D20. Measuringkexand calculating k2 leads to a direct determination of the
equilibrium constant, K, and hence AG for the protein unfolding process, which
may be localized to a particular element of secondary structure or regional
domain, or it may include the entire molecule.
Under somedestabilizingconditions,e.g.inthepresenceof
denaturants, at extreme pHs, or high temperature, the interconversion between
native and denatured states is slow with respect to the rate of amide hydrogen
exchange, i.e. k2 » k-1. This exchange reaction is first-order (EX1), and the
measured isotope exchange rate constant, kex, may be used to determine the
rate of protein unfolding, k1:
kex = k1 (5)
The EX1 mechanism would produce bimodal isotope patterns, i.e. two
separated peaks in the mass spectrum corresponding to the fully exchanged
and fully protected forms, respectively.15b In this case, the intensity of the two
peaks would change with time. Mass spectometric approaches to monitor
exchange reactions can be used to distinguish between these exchange
mechanisms, EX1 and EX2. The presence of bimodal mass to charge ratio
(m/z) patterns indicates 'correlated exchange' of all amide hydrogens within the
peptide. The 'correlated exchange' refers to conditions for which all of the
amide hydrogens in a region undergo isotopic exchange during one unfolding
event in this region. The ability to detect correlated exchange is especially
important, as it provides the basis for a more detailed description of the folding
and exchange processes.13
The rate constant for isotope exchange at each individual amide linkage
in a normally folded protein, kex, can be described by eq (6)
kex = kf + ku = (fi +K)k2 (6)
where kex is indicated as the sum of the contributions of exchange from folded
(kf) and unfolded forms (ku, EX2 kinetics) of the protein. Recent NMR studies
have used denaturants to distinguish between 6 and K.16 Structural changes
described by kf andkudifferin the magnitude of atomic displacement.
Hydrogen exchange in the folded proteins involves small atomic movements,
probably around 1 A, but sufficient to allow diffusion of 0D- and D20 to the
exchange site. In contrast, the unfolding of large segments of the backbone
require displacing many atoms several Angstroms from their equilibrium
positions in the native structure, and global unfolding requires gross movement
of the entire backbone. Thus, exchange from the folded proteins (kf) involves
primarily low-amplitude motions (small displacement), while exchange from
unfolded proteins (ku) requires high-amplitude motions. Engen et. al. showed
thatligandbinding-induced changesinthe exchange ratesofrapidly
exchanging NHs correlate with exchange directly from the folded protein,
thereby signifying changes in low-amplitude motions.17
Two different H/D exchange techniques, continuous and pulsed labeling,
have been developed to determine rates of folding and unfolding, as well as for
identifying structures of folding and unfolding intermediates (Figure 1.4).18
Continuous exchange involves exposing the protein to the deuterated medium
during the incubation period. The labeled protein is thus a measure of all
unfolding events that took place provided the exchange rate is much faster
than the unfolding event. In pulse labeling, the deuterated protein is a snapshotContinuous-labeling
1
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1
Equilibration in
H2O (neutral pH)
1
020 under denaturing
conditions such as
in urea solution or
heating for time x
14
Pulsed-labeling
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Deuterium Labeled Protein
1
Quench (pH 2.5, 0 °C)
Digest (pepsin, pH 2.5, 0 °C)
Deuterium Labeled Peptides
HPLC-MS
Mass Spectra of Labeled Peptides
Deuterium Level and Distribution
Figure 1.4. Experimental procedure for continuous and pulsed deuterium labeling15
of the unfolded protein that existed during the pulse. Many unfolding and
refolding events may have taken place during the incubation, but these are not
recorded because there is no deuterium available for exchange between the
pulses. Smith and co-workers have shown that continuous versus pulse
labeling can help to show when both mechanisms (kf and ku in Figure 1.3) are
operative indifferent regions of the proteiniflabeling under denaturing
conditions occurs to give bimodal isotope distributions. Thus for rabbit muscle
aldolase in 3M urea, when exchange in a given region of the folded state (k1) is
slow, a bimodal isotope distribution in the peptide used for study was observed
in both experiments. When exchange was rapid, poorly resolved isotope
distributions observed under continuous exchange conditions in peptides of
certain regions of the protein, were nicely resolved into bimodal distributions in
the pulsed labeling experiment.18
1.3 Thioredoxin
Thioredoxin (TRX) was chosen to study H/D exchange protocols in
which HPLC-MS or -MS/MS techniques were used for the analysis. TRX isa
small, (-12 kDa) multifunctional and ubiquitous protein characterized by having
a redox-active disulfide/dithiol within the conserved active site sequence: -Cys-
Gly-Pro-Cys-, the so-called "thioredoxin fold". TRX has been isolated and
characterized from a wide variety of prokaryotic and eukaryotic species.
Mammalian TRXs show about 25% sequence homology to thewell-
characterized E. coli protein with 108 residues. TRX has been foundto have
many activities invitro inribonucleotide reduction, photosynthesis, sulfite
reduction, and DNA polymerase.16
The disulfide linkage in the oxidized TRX is reduced by NADPH via the
action of a flavoprotein enzyme, thioredoxin reductase (TR). The reduced TRX
is a powerful protein disulfide reductase. Thus, TRX, TR, and NADPH,
collectively called the thioredoxin system, operate as a powerful NADPH-
dependent protein disulfide reductase system (Figure 1.5).19 For this function,
modifications of either active site cysteine (Cys-32 and Cys-35) through
alkylation or site-directed mutagenesis, causes a loss of activity. TRX is also a
requiredsubunitincertainbacteriophage systems,including T7 DNA
polymerase and filamentous phage assembly, where reduced thioredoxin is
functional but oxidized thioredoxin is not.2° The major determining factor in this
difference does not appear to be the presence of free thiol groups, since
mutants of TRX where one or both cysteines are replaced by Ala or Ser are
also partly functional.2° It suggests that the overall structure of the protein, and
not the chemical properties of the cysteine residues are important to the
regulation of this particular biological activity.
Protein-(SH)2
Protein-S2
NADPH + H+
Thioredoxin
Reductase
NADP+
Figure 1.5. Electron transport sequences by thioredoxin system.
TRX has been well-characterized biochemically, and the high-resolution
structures of oxidized and reduced forms of E. coli TRX have been determined
by X-ray crystallographyand NMR spectroscopy22 (Figure 1.6).Front view
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Figure 1.6. NMR solution structure and sequence of oxidized E. coli thioredoxin.1218
1.4 Electrospray ionization mass spectrometry (ESI-MS)
Electrospray ionization (ESI) is generally accomplished by forcing a
solution of the analyte through a small biased capillary in the presence of a
high electric field such that the fluid sprays into very fine droplets. This electric
fieldis usually imposed between the tip of the spraying capillary and a
counterelectrode (Figure 1.7). The initial fine droplets diminish in size due to
simple evaporation of the solvent in a drying gas at atmospheric pressure or in
a heated chamber at somewhat reduced pressure. As the droplets shrink,
nonvolatile ions are retained. The resulting increasein the electrostatic
repulsive forces between excess charges in the droplet eventually promotes
electrohydrodynamic disintegration into many smaller droplets. Asymmetry in
the distribution of charge at the droplet surface may stimulate "coulombic
explosion" of the droplet before reaching the Rayleigh limit (the point at which
repulsive forces between like charges in an electrolytic solution overcome the
cohesive forces of the solvent) for stability of a spherical charged droplet.
Finally, when the macroscopic solvent has evaporated, the analyte molecule
finds itself with residual charges attached; for positive ESI, protons presumably
attach at sites of high Lewis basicity.6
Because ESI can produce multiply charged ions, the mass-to-charge
(m/z) value of ions of macromolecules (up to several million daltons) may fall
within the mass range of most commonly used mass spectrometers. The high
sensitivity and specificity of ESI-MS also make it a useful technique for the
analysis of smaller compounds, such as those encountered in environmental
and drug metabolite studies, which generally produce singly charged ions.Liquid Sample
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+ + + + ++ +
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Figure 1.7. Electrospray Ionization Mechanism
The ESI technique has been a useful tool for the study of proteins and
peptides, nucleic acids, carbohydrates and lipids, pharmacology and drug
metabolism, and more recently organometallic and inorganic chemistry.
Because ESI is a "soft" ionization technique,itpermits investigations of
noncovalent associations of large biomolecules such as proteins.
ESI-MS can be operated with continuous sample flow introduction,
discrete sample injection as in flow-injection analysis (FIA), or on-line sample
separation systems such asliquidchromatography (LC) and capillary
electrophoresis (CE) (Figure 1.7). In particular, enzymes can be used to cleave
a protein selectively, and the resulting peptide mixture is separated by either
LC or CE, which is interfaced on-line to ESI-MS. ESI and assisted forms of ESI
can produce sample ions from solution flow rates ranging from 25 nl/min to
more than 1 ml/min.Sample Introduction
Continuous sample flow injection
Discrete sample injection
Liquid Chromatography
Capillary Electrophoresis
20
Mass Analyzer
Quadrupole
Magnetic Sector
1.- Time of Flight (TOF)
"1".. Ion Trap
Fourier Transform Ion Cyclotron
Resonance (FTICR)
Figure 1.8. Sample introduction methods and mass analyzers for ESI.
The most common types of mass spectrometers for ESI are the
quadrupole mass filter and ion trap. In the quadrupoles, mass separation is
achieved by establishing an electric field in which ions of a certain m/z have
stable trajectories through the field. The electric fields are created by placing a
direct current (dc) voltage and an oscillating voltage (ac voltage at radio
frequencies) on four metal rods, the quadrupoles. Adjacent rods have opposite
polarity. Ions pass through the center of the rods inscribing circles as they pass
the length of the rods. By increasing the magnitude of the dc and rf voltages
while maintaining the appropriate dc-to-rf ratio, stable trajectories are created,
allowing ions of greater m/z to pass through the quadrupoles and to reach the
detector. The ion trap mass analyzer was developed at the same time as the
quadrupole mass analyzer. The physics behind both of these analyzers is very
similar. Ions inside an ion trap can be mass analyzed to produce a mass
spectrum, or a particular ion can be trapped inside and made to undergo
collisions to produce fragmentation information. The primary advantage of an21
ion trap is that tandem mass spectrometry experiments can be performed
without having multiple analyzers.
Charge state distributions generated by ESI depend on the conformation
of the biomolecule in solution because different conformations in solution have
different numbers of exposed basic sites. Factors such as temperature, solvent
composition, and ionic strength can also influence biomolecular conformation
insolution. When the fractionof organic solvents such as methanol,
acetonitrile, and acetone is increased, a shift to higher charge states is
observed in the ESI-MS spectra.23 The influence of solution temperature upon
charge state distributions shows that at low temperatures, low charge states
are favored; at high temperatures where thermal denaturation can occur, high
charge states are observed.24
There is some evidence suggesting that gas-phase protein ions retain
the distribution of conformations that are present in solution. The evidence
indicates that ion structures in the final stages of ESI are influenced by both the
properties of the solution and the nature of the gas-phase ions that are
formed.25 Most H/D exchange studies to probe protein conformations have
been conducted in solution. Recently gas-phase H/D exchange has been used
to probe gas-phase ion conformations. Comparison of H/D exchange data
between these two phases should also provide information on the role of water
in protein structures particularly where conformational changes take place as in
folding pathways. Mc Lafferty and co-workers used fourier-transformion-
cyclotron-resonance(FTICR) MS toinvestigatetheconformationsof
cytochrome c; trapped ions were exposed to dilute concentrations of D20 vapor
(ca.10-7torr), and exchange levels were monitored for extended time
periods.26b Under these conditions, cytochromec was found to exist as multiple
conformational states that were stable for hours, whileinsolution, H/D22
exchange involves nearly all of the exchangeable hydrogens indicating rapid
equilibration among conformers.
ESI is relatively gentle and does not produce a significant abundance of
fragment ions, in contrast to electron ionization which produces many peaks in
the spectrum. Therefore, it has been necessary to develop techniques such as
tandem mass spectrometry (MS/MS) to induce fragmentation. Tandem mass
spectrometry (abbreviated MS" - where nrefers to the number of MS
experiments, i.e. MS3 means MS/MS/MS) allows one to induce fragmentation
and mass analyze the fragment ions. This is accomplished by collisionally
induced dissociation (CID) of a particular ion and then mass analyzing the
fragment ions (Figure 1.9).A precursor ionisselected using MS-1,
collisionally activating it in a region of relatively high pressure between MS-1
and MS-2, and then observing the product (fragment) ions by scanning the
second mass filter, MS-2.
Sample
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MS-1
Collision Gas
4,
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Induced
Dissociation
MS-2
fragment-Ion
spectrum
Figure 1.9. Schematic diagram of tandem mass spectrometry.23
For peptides and proteins, the polypeptide backbone is fragmented in the
CID cell in a predictable way giving rise to an ion series from which most of the
sequence can be deduced (Figure1.10).27 The fragment ions produced in this
process can be separated into two classes. One class retains the charge on the
N-terminus while cleavage is observed from the C-terminus. This fragmentation
can occur at three different positions, each of which is a sequence of ions
designated as types an,IN, and cn. The second class of fragment ions
generated from the N-terminal end retains the charge on the C-terminal end,
while cleavage is observed from the N-terminus. Like the first class, this
fragmentation can occur at three different positions, types xn, yn, and zn.
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Figure 1.10. Fragment Ions Obtained from Cleavage of a Peptide Backbone.2724
Sequence information can be obtained for peptides with molecular
weights up to 2500 Da. Larger peptides reveal at least partial sequence
information that often suffices to solve a particular problem. MS/MS data on
proteolytic peptides can be used to obtain the sequence and solve other
structural problems even forrelativelylargeproteins.Partial sequence
information by itself can be very informative. In many cases, the sequence of
the peptide is already known, and any sequence information from MS/MS
experiments can potentially point to where modification sites are located.
NMR spectroscopy has been used as a practical method for
determining the rates of deuterium incorporation at individual amide sites by
measuring the disappearance of the relevant proton resonance signals. Amide
hydrogen/deuteriumcontent canalso be measured by tandem mass
spectrometry at individual amino acid residues, however the results must be
interpreted with caution because of the potential for randomization during the
collision process. Deuterium present on amide nitrogens will be evident in a
shift to higher masses of the of the isotopic clusters of sequence ions as for
example in the bn and y,, ions when compared to the non-deuterated peptides.
From these data the H/D ratios at individual amide nitrogenscan be
determined.
For these determinations to succeed, a sequential set of ions must be
observed. Although earlier studies made use of several different ion series,
such as the bn, yn, and zn, more recent studies rely mostly on the bn ions.28 A
potential problem in using yn ions is that they are believed to be formed by the
transfer of a hydrogen from the N-terminal side of the cleavage site (Figure
1.11).29 This transfer of hydrogenor deuterium during analysis obviously would
lead to errors if not accounted for. In this case analysis of the bn ions is
preferable since no transfer of hydrogens in forming the acylium ionsoccurs25
duringfragmentation.However,highenergycollisionsrequiredfor
fragmentationsinCID MS/MS experimentscancauseintramolecular
scrambling of the amide hydrogens. Randomization occurs by the 'mobile
proton',i.e. by the added proton that forms the MH+. All exchangeable
hydrogens are subject to interchange26a and extensive H/D scrambling was
also observed in SORI-CID dissociation of cytochrome c26b analyzed by ESI-
FTMS though a-helical regions were found to remain intact by salt bridge
stabilization. There is some evidence that electron capture dissociation of
cytochrome c causes much less H/D scrambling.30
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Figure 1.11. Mechanisms for the formation of b and y ions26
Deng et al. showed the feasibility of detecting H/D exchange at peptide
amide linkages by mass spectrometry.31 Cytochome c was selectively labeled
at specific linkages and analyzed by CID MS/MS. They found a high level of
correlation between the predictions based on NMR and the CID b-fragments.
Similar analysis of the y ions showed several discrepancies, but, for the most
part the y ion series in their studies correlated very well with the NMR H/D
exchange rate constants. Thus, their results implied that CID MS/MS can be
confidently used to estimate deuterium levels at individual peptide amide
linkages.
In the following sections, H/D exchange experiments were carried out on
E. coli TRX and its alkylated adducts using thermally induced denaturation and
analysis by LC-ESIMS and LC-ESIMS/MS. In these schemes, the main effort
as focused on investigating the conformational change induced from the
reduction of TRX and noncovalent interactions between the alkylated portions
and the rest of the protein structure.27
CHAPTER 2
RESULTS AND DISCUSSION
2.1 Alkylation of E. coli thioredoxin and identification of the adducts
The tripeptide,glutathione,is abundant in most cells.32 Glutathione
reductase acts unidirectionally, so that the ratio of reduced glutathione to
oxidized glutathione in most cells is about 500 to 1. Because of its free thiol
group,itrepresents a major protective mechanism against oxidative stress
caused by a variety of chemical species such as hydrogen peroxide and organic
peroxides.
NADP+
Glutathione
Reductase
NADPH
2GSH
GSSG
Peroxides, oxidized metal ions,
or disulfide of two cysteines,...
Reduced Adducts
Reduced Glutathione, GSH = y-Glu-Cys-Gly
Oxidized Glutathione, GSSG SH
Figure 2.1. Electron transport sequences by glutathione system
The mutagenicity of 1,2-dihaloethanes ishighly dependent upon its
conjugation to glutathione by the enzyme glutathione S-transferase.33 The
conjugates thus formed can react with a variety of biomolecules such as nucleic
acids and proteins.34 Glutathione conjugation can induce cytotoxicity by forming28
S-(2-chloroethyl)glutathione (CEG), as a consequence of 1,2-dichloroethane
exposure.It can be hypothesized that the active site of proteins containing
"thioredoxinfold" such as thioredoxin, thioredoxinreductase, and protein
disulfide isomerase are in vivo targets for alkylation by glutathione conjugates.
Reduced E. coli thioredoxin was alkylated by the episulfonium ion derived from
CEG or S-(2-chloroethyl)cysteine (CEC).34b' 35 Tandem mass spectrometry was
used to confirm the position of alkylation on the protein.
2.1-1 Synthesis of alkylating agents.
S-(2-Chloroethyl)-glutathione (CEG) was synthesized in vitro from the
reduced glutathione (GSH) and 1-bromo-2-chloroethane according to the method
of Guengerich (Figure 2.2A).34a The CEG was obtained by precipitation and
used for alkylation of the protein without further purification. The molecular
weight of CEG was confirmed by mass spectrometry [369.83 (calculated), 369.8
(observed)] and the purity of CEG was found to be 60-70 % measured by HPLC.
S-(2-chloroethyl)-cysteine (CEC) was synthesized from cysteine and 1-bromo-2-
chloroethane by the same method. It was known that CEG reacts with DNA
through an episulfonium ion intermediate.35b
2.1-2 Reduction and alkylation of E. coil thioredoxin by CEG and CEC.
The disulfide linkage between Cys 32 and 35 of E. coli TRX was reduced
by the phosphine derivative, tris(2-carboxyethyl)phosphine (TCEP). Disulfides
are reduced by TCEP via a mechanism similar to that of the trialkylphosphines,
which have been used toquantitatively reduce organic disulfides.36 The
advantages of TCEP include its high solubility in water, activity below neutral pH,29
resistance to air oxidation, and selectivity towards disulfide bonds. Only a small
molar excess of TCEP is needed to quantitatively reduce disulfides.
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Figure 2.2(B). Alkylation of E. coil thioredoxin by CEG and CEC. The
alkylation positions were determined by tandem mass spectrometry.30
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Figure 2.3. Total ion chromatogram of the reaction mixture ofGS-TRX
and the observed and calculated molecular weights ofTRXadducts.
* Possible oxidation products of Met residues.
The reaction pathway was monitored by HPLC. The reduction of E. coli
TRX by TCEP was completed within 10 min. Then, CEG or CEC in buffer
solution was added in 50-fold excess to the solution of Red-TRX because CEG
orCECcan also react with water in aqueous buffer solution. The alkylation
reaction proceeds for about 1 hour at room temperature. For the completion of
the reaction, i.e. complete consumption of reducedTRXas monitored by HPLC,
moreCEGorCECwas added (2 x 25-fold). The reaction mixture was then
purified by preparative reverse phase HPLC. Mono-alkylated TRX adduct was
collected and freeze-dried under high vacuum. The molecular weights ofTRX31
adducts were measured by mass spectrometry. Minor side products included
bis- and oxidized mono-adduct (Figure 2.3).
2.1-3 Identification of modified sites in the alkylated TRXs by ESI-MS/MS
The modified site on GS-TRX was identified by enzymatic digestion and
tandem mass spectrometry. Itis already known that cysteine 32 is a major
alkylation site,340 and MS/MS experiments were carried out to confirm that
alkylation did, in fact, occur at this site. In the case of the mono-adduct, it was,
indeed, found that one of two cysteines is alkylated and the other is free. The
free thiol group in the mono-adduct was alkylated by iodoacetamide (IAA) to
produce the carboxamidomethylated derivative.Alkylationof the cysteine
prevented dimerization that otherwise occurs through intermolecular disulfide
bond formation. Urea (10 M) was added to denature the protein. Trypsin was
added to the protein solution. After 5 hours of incubation at 37 °C, the digestion
mixture was separated and mass-analyzed through reverse-phase HPLC-ESI-
MS. A very small peak in the total ion chromatogram was identifiedas the T3
fragment derived from CEG and IAA. Ions for the peptide, T3 (average MW
2371.7), showed the peaks at m/z 791.6 (+3) and 1186.8 (+2) (Figure 2.4).
MS/MS experiments were carried out on these two ions to identify the exact
alkylation site. CID experiments were carried out on both ions over therange of
collision voltages, 15V to 25V. However, the expected daughter ion peaks,y5 or
b14, that would identify the CEG-modified sites were not detected. Only weak b2,
b3, b4, b5, b6, b7, and y4 ions were detected. This result was thought to be due to
the low intensity of parent ions (m/z 791.6 and 1186.8). To obtain higher
intensities for these ions, several digestion and separation conditionswere
tested, however, those conditions were not effective, either.32
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Figure 2.4. ESI mass spectrum of alkylated T3 fragment of GS-TRX.
Since the trypsin digest did not yield the expected data to support
alkylation at Cys-32, it was decided to use another enzyme. Pepsin was selected
as an alternative proteolytic enzyme to digest TRX under acidic conditions which
involved 0.1M citrate buffer (pH 3.0). Initially digestions were carried out with the
free thiol group of GS-TRX not alkylated by IAA. HPLC-purified mono-adduct
was digested by pepsin in 4 M urea/0.1 M citrate solution. Through LC-MS, a
fragment including the modified site was found. The measuredmass value of
this fragment (1543.3) corresponded to the mass of the residue consisting of
amino acid 28-37 (Trp-Ala-Glu-Trp-Cys*-Gly-Pro-Cys*-Lys-Met,average MW
1543.8) with one of two cysteines* alkylated. The doubly charged ion peak (m/z
772.4) was subjected to CID to produce a series of b andy fragment ions. At 25
V collision energy, the selected fragment which included the alkylated sitewas33
unambiguously characterized (Figure 2.5 and Table 3.1). The daughter ion
spectrum indicates that the site of alkylation was Cys-32 exclusively as there was
no alkylation at Cys35. The ion denoted by ys (m/z 971.2) corresponds to
Cys32*-Gly-Pro-Cys35-Lys-Met (an asterisk indicates alkylated Cysteine). The y5
ion (m/z 535.2) corresponds to Gly-Pro-Cys35-Lys-Met. The mass difference
between ys and y5 ions (436.0) exactly matches the molecular weight (436.5) of
2-(S-glutathionyl) ethylcysteine at position 32. The y6 ion loses a glutamic acid
residue (E) from the ethylglutathionylated adduct to produce the signal at m/z
842. All fragment ions that included covalently attached glutathionyl group, y7, Y81
and y9, showed similar patterns with the glutamic acid residue missing (curved
arrows).
A minor bis-adduct was isolated from the alkylation product mixture, which
when digested with pepsin, produced two CEG-modified peptides. One is the
peptide that contains Cys-32, and the other contains Tyr-49. It was assumed,
therefore, that the second alkylation site is Tyr-49, since previous studies had
shown that the OH of this amino acid can be alkylated.34c However, because of
the low intensity of parent ions,it was not possible to confirm by MS/MS
experiments that Tyr-49 was, in fact, alkylated.
Sequencing of Cys-TRX was accomplished in the same manner. The
cysteinylethyl group also was attached at the Cys 32 position (Figure 2.6 and
Table 3.2). The reason for the exclusive alkylation at Cys-32 is most likely due to
the fact that the pKa of the Cys-32 thiol group is lower by several pH units than is
normally observed for cysteine residues. This is supported by possible favorable
interactions between this thiolate anion and the effective positive charge at the
N-terminal of the a-helix.37 In addition, further stabilization of the thiolate anion
can also arise from interactions with positively charged groups such as the basic
residues, Arg and Lys.38100
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Figure 2.5. (A) The ESI spectrum of a peptic fragment 28-37 of GS-TRX. (B)
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2.1-4 Sample pretreatment of purified modified TRXs
The charge state distribution spectrum of HPLC-purified GS-TRX at 25 °C
(Figure 2.7 (C)), unexpectedly shows that the majority of GS-TRX molecules are
populated as unfolded or open conformers. Charge states from 10+ to 16+
represent the unfolded or open conformers; charge states from 7+ to 9+
represent the compact or folded conformers. This unexpectedly high proportion
of unfolded GS-TRX is believed to be due to the use of C18 reverse-phase
HPLC for separation. A number of cases of protein structure disruption have
been reported when using LC for separation.39
Temperature-dependent alteration of ESI mass spectra of purified GS-
TRX was monitored by heating the protein stock solution to 85 °C. ESI mass
spectra at 45 °C (Figure 2.7 (B)) indicated very low intensities of ions in the
charge state envelopes for the unfolded form, i.e. these spectra showed stable,
compact conformers. Above 45 °C, the intensities of charge states representing
unfolded conformers (10+ to 16+) appeared, i.e. protein molecules start to melt.
Ion peaks representing charge states +7, +8, and +9 were attributed to the
folded form F. Ion peaks representing charge states +10 to +15 were ascribed to
the unfolded form U (see experimental details in section 2.2-3). The effect of
temperature was determined on the function of folded conformers in the mixture
by measuring F/(F+U) (Figure 2.8 and Table 3.3). At around 45 °C, the F/(F+U)
ratio was found to be a maximum. After initial equilibration at 45 °C for 15 min,
the charge state distribution of GS-TRX indicated that there wasa constant
F/(F+U) from 20 to 45 °C and a melting point at -55 °C. This result suggests that
the charge state distribution in a protein ESI spectrum reflects the heterogeneity
ofconformationalstatesinproteinfolding.
40After reverse-phase HPLC
separation, the structure of protein may be disrupted in a high-energy unfolded100
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Figure 2.7. The ESI mass spectra of HPLC-purified GS-TRX in 1% acetic acid
at different temperatures: (A) 54 °C, (B) 45 °C, and (C) 25 °C. Bis-alkylated
adducts are marked with an asterisk.38
state. With sufficient energy to overcome this kinetic trap, the conformation of
the protein became stabilized in a compact, native-like conformation. A decrease
of both the actual charge and the width of distinct charge state distributions at 45
°C can be interpreted in terms of the funnel-like nature of an energy landscape
which directs the ensemble ofprotein molecules toward more compact
structures, and ultimately to the native structure..' Hence, alkylated TRXs, GS-
and Cys-TRX, had to be pretreated by incubation in 1 % acetic acid at 45 °C for
15 min and cooled down to room temperature before being used in the
experiments.
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Figure 2.8. Temperature dependent variation of F/(F+U) for GS-TRX before
and after 45 °C equilibration.39
2.2 Thermal denaturation of E. coil thioredoxin and its derivatives (TRXs)
Thermally-induced unfolding of proteins has been studied extensively to
improve our understanding of the fundamental tenets of protein stability and
folding. Calorimetry is making enormous contributions to this area because it
provides a means of directly measuring enthalpy and entropy changes due to
unfolding.42 The variation of amide hydrogen exchange rates with temperature,
which may be a useful method for the thermal unfolding studies of proteins, has
received some attentions.Structuraland dynamic changes inducedby
temperature have been studied by amide hydrogen exchange.43
ESI mass spectra exhibit charge state distributions characteristic of the
conformational states in solution which enable one to differentiate between
folded, more compact and unfolded, less compact states. Some experimental
evidence is available showing the relationship between observed charge state
distributions in ESI mass spectra and the solution structures.44 There is a general
agreement that higher charge states correspond to unfolded, less compact
conformations and vice versa.
2.2-1 Online H/D exchange and ESI-MS experiments
This study was an attempt to learn more about the temperature-induced
denaturationof TRXs and theconformational dynamics duringthermal
denaturation. ESI mass spectrometric approaches, of necessity, make use of
volatile buffer solutions. Hiraoki et al. noted that the stability of TRX was
unchanged at pH 2.5 and 25 °C, and no signs of denaturation were detected by
proton NMR spectroscopy.45 Consequently, aqueous acetic acid was chosen as
the solvent system and the concentration was optimized to 1 % because it40
showed a uniform charge distribution pattern for the unmodifed as well as the
modified TRXs. Low pH and high temperatures show a synergistic denaturing
effect that decreases the melting temperature,Tin, thereby allowing direct
monitoring of the thermal unfolding transition of TRX by mass spectrometric
methods.
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Figure 2.9. Instrumentation for on-line H/D exchange-in experiments
The conformational dynamics of TRX during thermal denaturation were
investigated by performing online H/D exchange-in experiments as a function of
temperature and time. The method is based on a continuous flow setup (Figure
2.9). The solvent delivery line, the sample loop, and the injection valve were41
immersed in a water bath and equilibrated at the desired temperature (X °C). The
sample loop was used as exchange reaction capillary.
H/D exchange was initiated by a 50-fold dilution of a 0.85 gM protein stock
solution in 1% acetic acid into ice-cold 1% AcOD/D20 which resulted in a final
protein concentration of 0.018 iiM. The protein solution was injected as quickly
as possible into the sample loop in the desired temperature. The injection took
approximately 15-20s. To minimize exchange during this period, the glass body
of the syringe was precooled prior to injection. After the deuterium exchange
reaction in the sample loop, the protein solution was transferred from the sample
loop into the ESI source via a fused silica capillary which was immersed in an ice
bath to quench exchange-in and to facilitate refolding to thermally unfolded TRX.
The reported incubation periods represent the time that the protein spent in the
sample loop exposed to the HID exchange conditions. The maximum H/D
exchange reaction time, i.e. incubation time, depends on the volume of the
sample loop and the flow rate. The estimated exchange reaction time for this
setup (Figure 2.9) was 5 min for a flow rate of 6 µl /min or 10 min for 3 gl/min. To
obtain a strong ion signal, the flow rate had to be maintainedover 5 RI/min. The
total ion chromatogram indicated a strong and constant ion intensity for about 5
min (Figure 2.10).
The mass spectrum of Oxi-TRX in1 % AcOH/H20 exhibits a broad
distribution of charge states ranging from 7+ to 14+ (Figure 2.11). Themass
derived from deconvolution of the multiply-charged ions is 11,673.78 Da,a figure
which is consistent with the predicted mass, 11,673.45 Da. The conformational
dynamics from thermal unfolding of TRX and its alkylated adductswas monitored
by online H/D exchange-in experiments as a function of time and temperature.100
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Figure 2.10. Total ion chromatogram of H/D exchanged Oxi-TRX. The volume of
the reaction mixture (size of sample loop) was 33 gl. The flow rate was 6111/min.
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This continuous flow design allowed direct monitoring of protein unfolding
by ESI-MS. In these experiments, charge staes +7, +8, and +9 were ascribed to
the compact conformational state of TRX. Because of its high intensity, the 8-fold
charged ion peak was used to make quantitative comparisons of the ion peaks
after an exchange-in period of 105±10s (Figure 2.12). During the online
exchange-in experiment at 40 °C, the m/z value of the 8-fold charged ion peak of
Oxi-TRX increased to m/z 1468.1 after 105 sec which indicated an incorporation
of roughly 65 deuteriums (37% of exchangeable hydrogens). As the exchange-in
was monitored at 60 °C, the ion peak became broader and showed slight peak
splitting. At around 70 °C the spectrum showed two distinct peaks, m/z 1472.0
and 1476.8. The ion peak at lower mass value corresponds closely to the ion
peak which was observed during the hydrogen exchange experiment under
nondenaturing conditions (40 °C), and the peak at the higher mass value was
very close to the mass value that was observed for the ion of fully deuterated
TRX. Fully deuterated protein ions are shown as dotted peaks (Figure 2.13).
These were obtained from the fully denatured proteins that were incubated in 1%
AcOD/D20 at 80 °C for 1 hour. Reduced and alkylated adducts (GS- and Cys-
TRX) already showed two distinct peaks at approximately 50 °C and only one
peak at around 70 °C whose m/z value is very close to the ion peak of the fully
deuterated protein. This result suggests that Red-TRX and its alkylated adducts
have more unstable structures than Oxi-TRX because they showed the
conversion from EX2 to EX1 mechanism at lowered temperature.
As the exchange-in time increased, the ion peak at the higher m/z-value
increased inintensity, and the ion peak at the lower m/z-value diminished
(Figure 2.13). Peak evolution patterns at 50 °C were significantly different
between the Oxi-TRX and modified TRXs. Oxi-TRX showed it to be stable in the
EX2 kinetics, in which the mass spectrum shows a peak that gradually shifts with1468.1
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Figure 2.13. Evolution of the 8-fold charged ion peaks of TRXs during on-line H/D exchange-in
experiments in 1% AcOD/D20 at 50 °C. Time points refer to H/D exchange periods.
Dashed peaks were obtained by mass spectral measurements of the fully deuterated proteins.46
increasing exchange-in time to higher masses. In contrast, Red-TRX and its
alkylated adducts showed that two distinct mass peaks developed after a short
exchange-in timeindicatingthat the exchange took place by the EX1
mechanism. Deconvolution of the profiles by a non-linear algorithm (Peak Fit v.4,
AISN software) shows several peaks between the lower and higher mass peaks
in the 8-fold charged ion peak of Red-TRX after an incubation in 1% AcOD/D20
for 170 sec (Figure 2.14). Presumably, these peaks are produced from partially
unfolded intermediates or molten globule states that consist of core hydrophobic
3- sheets that resist unfolding. These unfolding intermediates can be rationalized
on the basis of "regional melting" of the Oxi-TRX,45 in which some amino acid
residues consisting of core p-sheets show very slow isotopic exchange rates.
Miranker et al. reported a similar pattern of transient protein folding intermediate
in the refolding study of hen lysozyme. The transient protein folding intermediates
were thought to be a result of cooperative folding of protein domains.10'
The evolution of the 8-fold charged ion peaks showed different rates of
conversion from lower mass (m/z) peaks to higher mass (m/z) peaks. The
conversion rate constants for TRXs were estimated from the varying intensities of
two separated 8-fold charged ion peaks at different temperatures. To simplify the
calculation, the mass peaks from partially unfolded intermediates were excluded,
and only the two extreme peaks (peaks A and D in Figure 2.14(A)) from
undenatured (folded) protein and fully denatured (unfolded) protein were chosen.
The conversion rate constants (kobs) were calculated by fitting the experimental
results,f/(f+u), to an equation f/(f+u) = Aexp(-kobst) where f and u are the
intensities of peaks A and D, respectively.46 The conversion rate constants of
TRXs at 50, 55, and 60 °C were obtained from the curves based on f/(f+u) and
time (Figure 2.15 A-C and Table 3.4 - 3.6).47
Time dependent analysis for the deconvolution of 8-fold charged ion peaks
were performed for Red-, GS-, and Cys-TRX (Figure 2.14(B)). The deconvoluted
peaks indicated three or four envelopes of isotope peaks corresponding to three
or four different structures. It is hard to say that whether there are one or two
intermediates between folded and unfolded forms (peaks A and D in Figure
2.14(A)) because the resolution of the mass peak was not good enough to
determine the exact number of intermediates. For example, the first two small
peak tops (peaks A and B in Figure 2.14(A)) separated by about 2 Da amounts
to a resolution of -800. To be able to determine the minimum number of real
peaks hidden within these profiles, a resolving power of at least an order of
magnitude greater would be required.
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Figure 2.14(A). 8-Fold charged ion peak () of Red-TRX after incubation
in 1% AcOD/D20 for 170 sec at 50 °C. Deconvolution of raw data was
obtained using a non-linear deconvolution algorithm (Peak Fit).10s
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Figure 2.14(B) 8-fold charge ion peaks () of Red-, GS-, and Cys-TRX
and their fitting with Gaussian functions during the on-line H/D exchange-in
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Figure 2.15 (A). Change in the fraction of folded conformers at 50 °C
with time. The rate constant kobs was obtained using equation f/(f+u) =
Aexp(-kobst).Red-TRX
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Figure 2.15 (B). Change in the fraction of folded conformers at 55 °C
with time. The rate constant kobs was obtained using equation f/(f+u) =
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Figure 2.15 (C). Change in the fraction of folded conformers at 60 °C
with time. The rate constant kobs was obtained using equation f/(f+u) =
Aexp(-kobst).52
The conversion rate constants of TRXs are summarized (Table 2.1). Cys-
TRX and Red-TRX indicated similar rate constants of conversion at 50 °C,
whereas GS-TRX had a much smaller rate constant. As the temperature
approached 60 °C, this difference in rate constants became smaller. At higher
temperatures, Red-TRX and alkylated adducts showed similar rate constants for
unfolding. However, at 50 °C, GS-TRX indicated a more compact structure
relative to Red- and Cys-TRX. This result suggests that the attached glutathionyl
group in GS-TRX has some interactions with TRX protein body which stabilizes
the adducted protein conformation.
Although the conversion rate constant, kobs, has almost the same meaning
as the unfolding rate constant, k1, in eq (5), they are not equivalent because kobs
was calculated with only mass peaks A and D (Figure 2.14) and the unfolding
intermediates were not taken into account. It is assumed that the actual unfolding
processes are much more complicated than the two-process H/D exchange
model (Figure 1.3).
Table 2.1. Conversion rate constants kobs (min-1) of TRXs in 1% acetic
acid solution.
T (°C) Oxi-TRX Red-TRX GS-TRX Cys-TRX
50
a 0.22 0.09 0.21
55
a 1.3 0.48 1.2
60 0.1 2.5 2.1
b
80 2.1°
a Separated peaks not detected. b Only the higher mass peak from fully
unfolded protein was observed. c Measured in 2 % acetic acid-d
solution.2953
2.2-2 Offline H/D exchange and ESI-MS experiments
The H/D exchange behavior of TRXs at room temperature was monitored
by offline H/D exchange (Figure 2.16). In this method, the protein stock solutions
were equilibrated in 1 % acetic acid solution (pH 2.6, 25 °C) and diluted 50-fold
with 1 % acetic acid-d/D20 (25 °C). At the moment of dilution, the timer was
started to measure the length of time for H/D exchange. At appropriate time
intervals, small aliquots of solution were taken from the diluted solution and
injected into the sample loop for mass measurement. A time-dependent mass
profile was obtained by plotting the percentage of deuterium incorporation versus
H/D exchange time (Figure 2.17 and Table 3.7- 3.10). The side chain
deuteriums were not back exchanged because D20 based delivery solvents were
used. The percentage of deuterium incorporation was calculated using eq (7).
Molecular weights of deuterated proteins were calculated by deconvolution with
multiply-charged ions from 7+ to 9+ because they showed strong peak
intensities.
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Figure 2.16. Experimental setup for offline H/D exchange-in.60
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The extent of H/D exchange of Red-TRX compared to Oxi-TRX indicated
approximately 7% increase in deuterium (D) incorporation. GS- and Cys-TRX
showed almost the same exchange profile with Oxi-TRX. The alkylated TRXs
showed a slight increase in protection against H/D exchange in comparison with
Red-TRX. There was no clear difference in D incorporation between GS- and
Cys-TRX. These results suggest that the reduction of a disulfide linkage exposes
some protectedamide hydrogenstothesolvent.Itisexpectedthat
conformational changes take place, and that in addition the alkylated portions in
GS- and Cys-TRX prevent H/D exchange of some unprotected hydrogens in
Red-TRX. These might be protected through noncovalent interactions such as H-
bonding and shielding. In order to localize the regions of TRX where exchange
was prevented by alkylation, the peptic digests were analyzed by LC-ESI-MS and
LC-ESI-MS/MS (chapter 2.3-2 and 2.3-3).
2.2-3 Analyses of bimodal charge state distributions
The charge state distributions of TRXs were monitored as a function of
temperature. The distribution of the charge states significantly changed as the
solution temperature was increased to 50 °C or above (Figure 2.18). The
experimental setup was the same as that used for online H/D exchange (Figure
2.9). The only difference was that all solvents for delivery and protein dilution
were normal H2O based solvents. Mass analyses of the injected protein samples
in the sample loop were preceded by at least 2 minutes incubation periods to100
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Figure 2.18. ESI mass spectra of Oxi-TRX in 1% acetic acid at different temperatures:
(A) 85 °C, (B) 65 °C, and (C) 25 °C. Ion peaks at m/z 1668, 1460, and 1298 representing
charge states 7+, 8+, and 9+, respectively, were attributed to the folded form, F.
Ion peaks at m/z 1168, 1062, 973, 899, 835, and 779 representing charge states 10+
to 15+ were attributed to the unfolded form, U. A minor unidentified impurity is marked
with an asterisk.57
establish equilibrium. The changes in charge state distributions are evident in the
denaturation transition curves plotted as a function of temperature and F/(F+U)
(Figure 2.19 and Table 3.11). The intensity of the folded conformer is designated
F, which is the summation of the peak intensities from 7+ to 9+ charge states.
The unfolded conformer, U, is represented by the summation of 10+ to 16+
charge state peak intensities.
As the temperature is gradually increased toward conditions that favor
unfolding, the folded conformation initially changes very little, if at all. There may
be increases inflexibility and localized conformational alterations, but the
average structure is unchanged. This stable phase was observed as gradually
decreasing absorption intensities by near UV-CD experiments (Figure 2.22 and
2.23). The protein then unfolds completely within a narrow range of temperature,
of about 10 °C. The abruptness of the unfolding transition is indicative of a very
cooperative transition for thermal unfolding.
At room temperature, Oxi-TRX is the most compact conformer, and Red-
TRX has the least compact structure. The difference in F/(F+U) between Red-
and Oxi-TRX is more than 0.2. This result is comparable to those from an NMR
study, in which Red- and Oxi-TRX were found to have very similar rates of H/D
exchange, and thus were assumed to have similar structural or backbone
dynamics.47 Significant differences were observed onlyin the active site
sequence and regions close to the active site. GS-TRX has an intermediate
fluffiness, while Cys-TRX and Red-TRX showed almost the same F/(F+U). The
difference in melting temperature (Tm) between Oxi- and Red-TRX is about 15
°C, which is in close agreement with previously reported data from NMR and CD
studies.45 Cys-TRX showed almost thesame Tm as that of Red-TRX, while GS-
TRX showed a little higher Tm value relative to Cys-TRX. These results also1
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Figure 2.19. Denaturation curves of TRXs in 1% acetic acid.
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reflect that the glutathionyl group on GS-TRX has some stabilizing effects on the
conformation of the protein whereas the cysteinyl group does not.
2.2-4 Spectroscopic experiments : UV absorption and circular dichroism
The ultraviolet (UV) absorption spectra of TRXs in 1% acetic acid solution
were obtained (Figure 2.20). The reduction ofthe disulfide bond in the protein
causes small but significant changes in the absorption spectrum.In the range
between 230 nm and 300 nm, the effects of aromatic amino acidsPhe, Tyr, and
Trpcontribute to the absorbance. The most intense band is due to tryptophan
(W) at around 280 nm. The small changes in absorbance means that there is a
change in the chemical environments of the two tryptophansW28 and W31-
near the active site. The conformational changes due toreduction and alkylation
may cause the alteration of environments of two tryptophansbecause they are
very close to the active site.
Oxi-TRX
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GS-TRX
Cys-TRX
0.2 -
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0
240 260 280 300 320 340
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Figure 2.20. UV spectra of TRXs (34 p.M in 1% AcOH).60
The aromatic region of the CD spectra of TRXs were measured in the
near-UV range (250-360 nm) (Figure 2.21). The reduction of the disulfide bond
and alkylations bring about significant changes in the near UV-CD spectrum,
which suggests at least some of the aromatic residues acquire a different
environment and/or conformation. These changes seem to take place without the
involvement of the backbone. There are significant differences between Red-
TRX and modified TRXs, while no difference seems to exist between GS- and
Cys-TRX, which is similar to the pattern observed in the UV spectra.
CD spectra are widely used for detecting and measuring the various
conformational components of proteins in solution.48 The temperature-dependent
unfolding transition determined by analysis of the charge state distributions in the
ESI mass spectra coincided with the unfolding transition observed in the near-UV
CD that reflected the collapse of the tertiary structure (Figure 2.22). The change
of intensities at 280 nm are shown (Figure 2.23 and Table 3.12). The unfolding
transitions,i.e.the melting temperatures (Tm),indicatesimilarresultsin
comparison with the graph (Figure 2.19) from the analyses of the charge state
distribution in the mass spectra.
Far UV-CD spectra of TRXs at 25 °C and pH 2.5 were measured (Figure
2.24). All proteins show the broad minimum at around 220 nm, the cross-over
points between 205 and 207 nm, and the positive maxima around 197 nm. The
secondary structural elements were calculated from these spectra and a basis
set of 20 proteins by singular value decomposition.48 The calculated secondary
structural elements of TRXs (Table 2.2) shows significant changes in a-helix and
13-sheet by the reduction of the disulfide bond in Oxi-TRX, which suggests that
the reduction changed the position of the backbone, which is not in agreement
with results from NMR experiments.x
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Figure 2.24. Far UV CD spectra of TRXs (10 mM TRIS.HCI, pH 2.5, path
length 0.01 cm)63
Table 2.2. Estimation of secondary structural elements of TRXs based on
far UV CD spectra and singular value decomposition.48
a-Helix310Helix0-sheet0-TurnPoly ProOthers
Oxi-TRX .34 .07 .13 .10 .13 .23
Red-TRX .17 .04 .28 .10 .08 .35
GS-TRX .19 .03 .25 .10 .10 .33
Cys-TRX .19 .02 .26 .09 .09 .35
The CD spectra for many proteins can be predicted successfully using this
calculation. However, some protein CD spectra are not analyzed successfully
due to insufficient basis sets or equations to solve for all of the unknowns that
contribute to the CD. At least, this calculation showed the changing in CD spectra
with the reduction of the disulfide linkage and alkylation.64
2.3Structural features of TRXs analyzed by H/D exchange
The protein fragmentation/MS method was used to locate sites of amide
hydrogen exchange on E. coli TRX and its alkylated adducts. H/D exchange
experiments were preceded by the identification of peptic peptides because
pepsin cleaves proteins unpredictably. For fragment-specific H/D exchange
information, TRXs were equilibrated in 1% acetic acid (pH 2.6) because the
results are then comparable with global H/D exchange obtained under the same
conditions (section2.2).For site-specific H/D exchange experiments, TRXs
were equilibrated in 10 mM phosphate buffer (pH 5.7) when the results were to
be compared with NMR rate constant data. Previous spectroscopic data showed
that the influence of pH on the near-UV CD spectrum of Oxi-TRX between pH 3.0
and 6.5 was small.49 It suggested that local conformational changes, observed
through the aromatic side chains, take place without affecting the backbone
structure. NMR data also indicated that the influence of pH was negligible in both
Oxi- and Red-TRX in the pH range from 2.5 to 12.45 Itis assumed that the
conformational differences of TRXs at two different pHs, 2.6 and 5.7, are
negligible.
2.3-1Peptide mapping and sequencing of thioredoxins (TRXs)
Proteolytic digestion of TRXs with pepsin at a weight ratio of enzyme to
substrate E/S = 1/2 under slow H/D exchange conditions (1% acetic acid, pH 2.6,
0 °C, 5 min) were successful except in the case of Oxi-TRX. This protein form
was poorly digested (Figure2.25),which supports the notion that it has the most
compact 3-D structure. However, with just a small amount of proteolytic
fragmentation, peptide mapping of Oxi-TRX digest was possible. The peptic1.0E+09
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Figure 2.25. Total ion chromatograms of peptides produced from peptic digestion of TRXs. Asterisks represent
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peptides of TRXs were observed between 7 and 13 min retention time. The
fragments from pepsin autoproteolysis were easily recognized through the blank
test. The retention time of these fragments was 2-5 min.
Digestion was quenched simply by injecting the peptic digest onto an LC
column. Peptic peptides were separated and identified by on-line HPLC-MS
(Figure 2.26). Because peptide mapping and sequencing are necessary and
preliminary experiments for H/D exchange, digestion and separation were
adjusted for slow H/D exchange conditions. The entire system from the injection
valve to the column outlet just before the mass spectrometer were immersed in
an ice-bath.
Since pepsin cleaves proteins rather unpredictably, peptide masses alone
areinsufficientfor the unambiguous determinationoftheiridentification.
Therefore, all peptides were identified with a combination of molecular weight
information and MS/MS data. An example of this ambiguity, and its resolution, is
demonstrated for mass peak, m/z 1145.1, from the digest of Oxi-TRX (Figure
2.27). Seven possible peptides from the sequence of Oxi-TRX could correspond
to the mass m/z 1145.1 ± 1 with charges of 1+ or 2+ (Figure 2.27 (A)). The
MS/MS spectrum of the mass peak, m/z 1145.1, was identified as corresponding
to fragment 80-101 (Figure 2.27(B)). Seventeen peptides identified through this
procedure for each TRX (Figure 2.28) represented about 94% of the total protein
sequence. All these fragments were confirmed by tandem mass spectrometry
(Table 3.13). In the active site region, pepsin showed different patterns of
digestion for the alkylated TRXs. In the native TRXs, Oxi- and Red-TRX,
segments 28-39 were obtained, whereas only segments 28-37 were found for the
alkylated TRXs. It was assumed that the peptic cleavage site was changed by
alkylation of the protein.0.05% TFA/H20
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Figure 2.26. Instrumentation (HPLC-MS) for peptide mapping and sequencing of pepsin digest of TRXs.68
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Figure2.28. Peptides identified in the pepic digests of TRXs by tandem mass spectrometry70
2.3-2 H/D exchange of TRXs, proteolysis, and the determination of deuterium
content in peptide segments
The general procedure used in the protein fragmentation/MS approach for
determining amide hydrogen exchange content in intact proteins is based on a
protein fragmentation method described previously (Figure 2.29).12 Following the
deuterium exchange-in step, isotopic exchange at peptide amide linkages is
usually quenched by reducing the pH and temperature. The extent of back-
exchange was minimized by performing the digestion and HPLC separation at 0
°C and pH 2-3.50 In this experiment, simply decreasing temperature to 0°C was
sufficient because the pH was already at2.6.Isotopic exchange in unfolded
polypeptides is slowest at pH2-3(Figure 1.1). For this quench condition, the
half-life for isotopic exchange of peptide amide linkages is30-120min.
13b, 12b
The same microbore HPLC-MS system that was used for peptide mapping
was used for separation and mass analysis of the H/D-exchanged TRX samples
(Figure 2.26) although the gradient conditions for the HPLC were slightly
changed. All peptic peptides were eluted from the LC column within 10 min
retention timesinorder to minimize deuterium loss. Because the amide
deuterium level was determined directly from the molecular weights of the
peptides,it was not necessary to isolate the peptides prior to analysis. By
optimizing the chromatography for speed rather than resolution, the extent of
back-exchange that occurred during analysis was kept low. Results were
obtained by incubating proteins in 1% AcOD/D20 (pD2.6)at room temperature
for different incubation periods. Five-microliter (0.4 nanomole) aliquots of the
incubation mixture were removed, adjusted to 0°C to quench hydrogen
exchange, and digested with pepsin for 5 min. The proteolytic digestswere
analyzed by HPLC-ESIMS to determine the deuterium content of the peptides.71
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Figure 2.29. Diagram of the general procedure used to determine the deuterium
content of the peptic peptides in H/D exchanged TRXs.72
Amide and side chain hydrogens in peptides underwent isotopic exchange
with the solvent during digestion and fractionation by HPLC. Even under slow
H/D exchange conditions (0°C and pH 2-3), deuteriums located on side chains
and on the N- and C-termini of the peptides are completely back-exchanged to
protons during HPLC separation because the exchange rates of these hydrogens
are several orders of magnitude faster than the exchange rates of peptide amide
hydrogens. As a result, the increase in the molecular weights of peptides
analyzed by this procedure is a direct measure of the number of peptide amide
deuteriums present in the peptide.
ESI mass spectra of two peptic fragments, which include residues 28-39
and 59-80, will be used to illustrate two very different types of hydrogen
exchange behavior found when Oxi-TRX was labeled continously for 0.5, 10, and
30 min (Figure 2.30). Reference spectra of the same peptides taken from Oxi-
TRX that contained no deuterium (0% ref) and Oxi-TRX that was completely
exchanged in D20 (100% ref) are presented in the top and bottom panels. These
reference spectra were used to determine the extent of deuterium loss during
digestion and HPLC separation. In addition, the 0% ref and 100% ref spectra
served as references for totally folded and unfolded states of proteins.
Doubly charged ion peaks of fragment 28-39 showed gradually increasing
one envelope mass peaks (Figure 2.30 (A)). Each of the molecular ion patterns
have contributions from the natural abundance of isotopes (13C, 15N, 180, etc.)
and/or an excess of deuterium. This fragment is structurally homogeneous in all
Oxi-TRX molecules during the entire time of incubation. For the region including
the fragment 28-39, opening and refolding occurs many times before exchange
takes place, i.e. this fragment follows EX2 mechanism (k2 « k_1).
In contrast, triply charged ion peaks of fragment 59-80 displayed a
bimodal isotope pattern after a short incubation period in D20 (Figure 2.30 (B)),73
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Figure 2.30. ESI mass spectra of the doubly charged molecular ions of
fragment 28-39 and the triply charged molecular ions of fragment 59-80
derived from non-deuterated (0% ref), partially deuterated and completely
deuterated (100% ref) Oxi-TRX.
suggesting that hydrogen exchange is very slow in this segment of some Oxi-
TRX molecules and very fast in other molecules. The increasing higher mass
peaks suggest that this segment had spent enough time in the unfolded state
before refolding to allowits amide protons to completely exchange with
deuteriums, i.e. this fragment follows the EX1 mechanism (k2 » k_1). The
intensity of the low-mass envelope of isotope peaks indicates that the fraction of
Oxi-TRX that was folded during the period of incubation, while the intensity of the74
high-mass envelope of isotope peaks indicates the fraction of molecules that was
unfolded during the incubation period. The observed mass difference between
high- and low-mass envelopes, 2.8 ± 0.5 (m/z), corresponded to 8.4 ± 1.5
deuteriums. Only fragments 59-80 and 81-101 of Oxi- and Red-TRX showed
bimodal isotope peak patterns, i.e. the EX1 mechanism (Table 2.3). This result
suggests that the region including amino acid residues 59-108 of Oxi- and Red-
TRX is more flexible than that same region in alkylated TRXs.
Table 2.3. Summary of EX1() and EX2 (0) kinetics of peptic peptides
obtained from H/D exchange-in experiments of TRXs in 1% AcOD/D20
FragmentsOxi-TRXRed-TRXGS-TRXCys-TRX
1-12 0 0 0 0
13-24 0 0 0 0
28-39 or 37 0 0 0 0
45-58 0 0 0 0
59-80 0 0
81-101 0 0
The firststep for estimating the EX2 mechanismisan accurate
determination of the deuterium level for each mass peak under different D20
incubation times. As mentioned above, some isotopic exchange occurs during
both digestion and HPLC analysis. The deuterium content of the peptides may
increase or decrease during digestion, depending on the D20 level in the digest.
Since the HPLC mobile phase contains no D20, the peptides can only lose75
deuterium during HPLC analysis. Measured deuterium levels can be adjusted for
artifactual isotopic exchange that occurs during digestion and HPLC fractionation
(eq (8)).
D=m m"x N
ml00%mo%
(8)
In the expression (eq (8)), D is the number of deuteriums present in a
particular segment of the protein after incubation in D20 for time t, and mo%, m,
and m100% are the average molecular masses of a peptide obtained by analysis
of nondeuterated, partially deuterated and fully deuterated samples, respectively.
N is the total number of peptide amide hydrogens in the peptide.
The deuterium content in the peptide fragment 28-39 of Oxi-TRX was
determined from the centroid of a Gaussian-shaped peak that resulted from the
isotopic composition of the ion (Figure 2.30). The deuterium content of the 28-39
segment in the protein was deduced from the deuterium content of this peptide,
after adjusting for deuterium gain/loss during digestion and HPLC separation. To
make this adjustment, nondeuterated as well as fully deuterated Oxi-TRX was
analyzed by the same procedure. Completely deuterated proteins were obtained
by incubating TRXs in 1% AcOD/D20 at 80 °C for1h. Having chosen
experimental parameters to minimize isotopic exchange at peptide amide
linkages during analysis, the peptic peptides of TRXs showed that recoveries of
deuterium at peptide amide linkages were in the range 80- 90%.
Data were processed by centroiding an isotopic distribution corresponding
to the +1, +2, or +3 charge state of each peptide. Deuterium levels were plotted
versus the exchange-in time and fitted with a series of first-order rate terms
according to eq (9) where D is the number of deuterium present, N is the number76
of peptide amide linkages in a segment, and the k1 are hydrogen-deuterium
exchange rate constants for each peptide linkage. The exchange rate constants,
k1, were varied to obtain the best fit between the experimental data and eq (9).17
t D= NLexp
(9)
Deuterium levels for peptic fragments of all TRXs were plotted versus D20
incubation time (Figure 2.31-34 and Table 3.14 - 3.17). Although specific
exchange rate constants have not been determined for each amide hydrogen,
the range and distributionofrate constants can be estimated by fitting
parameters into the first-order rate expression, eq (9), with the experimental
results. A quantitative assessment of hydrogen exchange rates was made by
fitting data to the following expression, which represents a four-component
model, eq (10), modified from eq (9).
1 2 b
y = N (P1exp-P2x+ P3 exp-P4x+ P5 exp-P6x+ (NP,P3P5 ) exp-P7x )
(10)
According to this model, the total number of amide hydrogens, N, is
divided into four groups, Ply P3,P5, and (N- P1- P3 -P5), with exchange rate
constants P2, P4, P6, and P7, respectively. Values for P1-7 for each peptide of the
TRXs are given by fitting deuterium levels to eq (10) (Table 2.4). Four different
exchange rate constants, P2, Ply P6, and P7, represent four categories of rate
constants, very fast, fast, slow, and very slow, grouped according to their
exchange rates. For the exchange times used in this study, 30 s to 3 h, only
those rate constants in the range 0.0033 min-1 could be determined.1-12
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Table 2.4. Numbers of amide hydrogens that have exchanged with H/D exchange
rate constants (rate groups) for common peptides from TRXs.a
PeptidesTRXs
# of
NH
Rate groupsb
very fast fast slow very slowb
1-12 Oxi-TRX 11 4.0 (>3.0)2.5 (1.3) 1.0 (0.04)3.5 (<0.003)
Red-TRX11 4.0 (>3.0)2.5 (1.14) 1.9 (0.1)2.6 (<0.003)
GS-TRX 11 5.0 (>3.0)2.6 (0.6) 0.7 (0.1)2.7 (<0.003)
Cys-TRX11 4.2 (>3.0)3.0 (1.0) 1.1 (0.1)2.7 (<0.003)
13-24 Oxi-TRX 11 1.0 (>3.0)4.0 (0.2)2.5 (0.05)3.5 (<0.003)
Red-TRX11 2.0 (>3.0)3.0 (0.3)2.6 (0.04)3.4 (<0.003)
GS-TRX 11 2.8 (>3.0)2.8 (0.1) 1.6 (0.01)3.8 (<0.003)
Cys-TRX11 1.6 (>3.0)3.1 (0.2) 1.3 (0.02)5.0 (<0.003)
28-39 Oxi-TRX100.5 (>3.0)4.0 (0.4)2.7 (0.04)2.8 (<0.003)
Red-TRX102.0 (>3.0)3.0 (0.5)3.0 (0.05)2.0 (<0.003)
28-37 GS-TRX 9 1.5 (>3.0)2.5 (0.3) 1.0 (0.1)4.0 (<0.003)
Cys-TRX7 1.0 (>3.0)2.0 (0.9) 1.0 (0.03)3.0 (<0.003)
45-58 Oxi-TRX134.0 (>3.0)4.0 (0.3)3.3 (0.03)1.7 (<0.003)
Red-TRX132.1 (>3.0)3.3 (0.4)4.9 (0.06)2.7 (<0.003)
GS-TRX132.0 (>3.0)7.1 (0.4)2.1 (0.05)1.8 (<0.003)
Cys-TRX13 1.0 (>3.0)6.9 (0.6)3.0 (0.06)2.1 (<0.003)
59-80 GS-TRX185.3 (>3.0)8.3 (0.2) 1.7 (0.14)2.7 (<0.003)
Cys-TRX184.2 (>3.0)8.5 (0.2)3.0 (0.17)2.3 (<0.003)
81-101GS-TRX201.0 (>3.0)14.0 (0.7)3.5 (0.06)1.5 (<0.003)
Cys-TRX204.0 (>3.0)10.0 (0.3)3.7 (0.06)2.3 (<0.003)
a Distribution of rate constants for H/D exchange of peptide amide hydrogens
estimated by fitting deuterium exchange results shown in Figures 2.31-34 to eq
(10). b The number of amide hydrogens that exchange with the rate constant
(min-1) indicated in parentheses. b The number ofvery slowly exchanging amide
hydrogens was determined by subtracting the number of amide hydrogens
exchanged in 3h from the total number of amide hydrogens in each segment, i.e.
(N-P1-P3-P5) (eq (10)).82
For the N-terminal peptide of Oxi-TRX consisting of residues 1-12, there is
a total of 11 amide hydrogens in the backbone; 4.0 exchange with rate constants
greater than 3 min-1, 2.5 exchange with rate constants equal to 1.3 min-1, 1.0
exchanges with a rate constant equal to 0.04 min-1, and 3.5 exchange very
slowly with rate constants less than 0.003 min-1. The categories of very fast and
very slow include amide hydrogens that exchange either too fast (kex > 3 min-1) or
too slow (kex < 0.003 min-1). The fast and slow exchange categories were
assigned on a relative basis in each peptic segment. For example in GS-TRX,
the rate constant 0.1 min-1 for peptide 13-24 is in the fast category, whereas for
peptide 1-12 it is in the slow category.
The results in Table 2.4 were plotted to more easily show the number of
amide hydrogens that exhibit similar exchange rates for common peptic peptides
from TRXs (Figure 2.35). The number of amide hydrogens that exchange in the
very fast category, i.e.kex >3 min-1, is indicated on the right of each panel, while
the number of amide hydrogens with very slow exchange rates is indicated on
the left of each panel. In the data analysis, only very fast and very slowly
exchanging amide hydrogens have been focused because they are directly
connected to the protein's conformational changes such as ligand bindingor
partial unfolding.'
Small changes observed in the four rate groups for peptide 1-12 suggest
that either the reduction of the disulfide linkage between Cys-32 and Cys-35or
alkylation of the Red-TRX causes slight changes in the conformation and stability
of this segment. In peptide 13-24, the reduction and alkylation increases the
number of very fast exchanging amide hydrogens by 0.6-1.8. For slowly
exchanging amide hydrogens, only Cys-TRX showed an increase, thatwas
about one. This result suggests that the conformational changes resulting from6
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Figure 2.35. Distribution of amide hydrogen exchange rates in peptic fragments of
Oxi-TRX (), Red-TRX (0), GS-TRX (*), and Cys-TRX (). The number of amide
hydrogens that have exchanged versus their mean exchange rates is displayed.
Results were obtained by fitting parameters in eq (10) to deuterium exchange
results. The fragments 28-39 were taken from Oxi- and Red-TRX, and fragments
28-37 were taken from GS- and Cys-TRX.84
the reduction and alkylation in the active site which contains Cys-32 and 35
residues influence the adjacent segment 13-24, however, slightly.
Four component model analysis clearly differentiates the conformational
changes in the active site segments 28-39 or 28-37. Even though itis not
appropriate for these segments to be compared because they have different
numbers of peptide amide hydrogens, the results show they are significantly
different. The very fast and very slow rate groups showed dramatic changes
which were caused by reduction of the disulfide linkage and by the alkylation at
Cys-32. The reduction increased the number of very fast exchanging amide
hydrogens by 1.5. The alkylation decreased the hydrogen number in the very fast
rate group of Red-TRX by 0.5 and 1 for GS-TRX and Cys-TRX, respectively. The
very slow rate group showed that 2, 2.8, 3, and 4 of very slowly exchanging
hydrogens were found in Red-, Oxi-, Cys-, and GS-TRX, respectively. These
results suggest that the reduction and alkylation changed the conformation in the
active site. That is, the increase of very fast amide hydrogens by reduction
implies there is enhanced flexibility in the vicinity of the active site. The changes
in the very slow exchange rate group indicate a change of the intramolecular
hydrogen bonding.
The peptide 45-58 showed an unexpectedresult.The reduction
decreased the number of very fast exchanging hydrogens by two and increased
the number of very slowly exchanging hydrogens by one. This result suggests
that the reduction made the active site region more flexible, however, it appears
to have made the adjacent region 45-58 more rigid. In the peptides 59-80 and
81-101, there is no direct relationship between native (Oxi- and Red-TRX) and
alkylated TRXs (GS- and Cys-TRX) because Oxi- and Red-TRX showed bimodal
isotopic mass peaks. Four-component analysis showed little or no difference
between Cys- and GS-TRX in the peptides 59-80 and 81-101.85
The fragments 59-80 and 81-101 of Oxi- and Red-TRX showed two
distinct mass envelopes after a short incubation period in 1% AcOD/D20 at room
temperature (Figure 2.36). This is evidence for correlated exchange in the region
of these two segments. When correlated exchange prevails, the mass spectra
show bimodal isotope patterns and the continuously changing relative intensities
of two envelopes of isotope peaks are a direct measure of the population of
folded and unfolded forms. The lower mass peak corresponds closely to the ion
peak from the nondeuterated protein (0% ref.), and the higher mass peak is very
close to the ion peak from the fully deuterated protein (100% ref.).
By measuring conversion rates from the lower to the higher mass peaks,
the unfolding rate constant, k1, could be obtained from the EX1 mechanism
(Figure 2.37). Different unfolding rate constants are an indication of different
lifetimes in an unfolded state. The longer a fragment stays in the unfolded state,
i.e. the faster a fragment unfolds, the faster the lower and higher mass peaks
change in relative intensities. The intensity of the higher mass peak contains the
accumulated H/D exchange information because thispeak includes the
population of molecules that were unfolded as well as molecules that unfolded
then refolded during the incubation time.
The unfolding rate constants, k1, of each segment were obtained by fitting
F/(F+U) to the equation, F/(F+U) = Aexp(-kit), where F and U are the intensities
of lower and higher mass peaks in the bimodal isotopic profiles, respectively. By
the reduction of the disulfide bond, the unfolding rate constant of peptide 59-80
was doubled, and the unfolding rate constant of peptide 81-101 was tripled.
Thus, continuous H/D exchange labeling can be used to identify regions of
proteins that unfold at different rates.
These results suggest that even small conformational change in the active
site can affect the stability and dynamics of remote regions. Because the H/D0% ref
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Figure 2.36. Molecular ion peaks of peptic peptides 59-80 and 81-101 of Oxi- and Red-TRX in ESI mass spectra
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exchange time course for the peptic fragments 28-39 already showed significant
differences between Oxi- and Red-TRX, the combined results suggest that the
reduction of the disulfide linkage triggered conformational changes in the entire
protein. These results support previous temperature-dependent global H/D
exchange and thermal unfolding behavior that showed a difference in melting
temperatures of 15 °C between the Oxi- and Red-TRX.4589
2.3-3 H/D exchange of TRXs, proteolysis, and tandem mass spectrometry for
residue-specific hydrogen exchange
Collision-induced dissociation tandem mass spectrometry (CID MS/MS)
was used to measure the extent of H/D exchange at individual amide linkages
of TRXs (Figure2.38).Non-deuterated,partiallydeuterated, andfully
deuterated proteins were digested and analyzed by HPLC-MS used for the
fragmentation /MS method (Figure 2.26). Phosphate buffer solution (10 mM,
pH 5.7) was selected for equilibration and exchange-in experiments because
previous NMR experiments for hydrogen isotope exchange of Red- and Oxi-
TRX were carried out in this particular buffer solution 47 and the intention here
was to draw comparisons between NMR and mass data. For deuterium
exchange-in experiments, the equilibrated TRXs were exposed to D20
phosphate buffer solution for 20 sec at room temperature.
After brief exposure to D20 and quenching, all TRXs except Oxi-TRX
were digested by pepsin without prior treatment. As mentioned in chapter 2.3-1,
Oxi-TRX was poorly digested under slow exchange conditions and as a result
the signals of peptic peptide ions were too weak on which to perform MS/MS
experiments. Urea was used to denature Oxi-TRX and to enhance the digestion
by pepsin. Pre-cooled concentrated urea solution was added to labeled Oxi-
TRX during the mixture being quenched.
The molecular weight of biomolecules can be deduced by deconvolution
from a series of peaks of multiply charged variants of the analyte because these
multiply charged species differ by a consecutively decreasing number of
charges as in/z increases. Generally, the molecular weight of a charged ion can
be calculated from eq (11).Oxi-TRX, Red-TRX,
GS-TRX, or Cys-TRX
Add D20, pH 5.7
Equilibrate
25 °C, pH 5.7
Pepsin digestion
5 min, 0 °C, pH 2.5
Peptides
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ESI-MS
Select precursor ions
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Figure 2.38. Strategy for the determination of deuterium levels at individual
peptide amide linkages.91
M + nX
m
n
M = mn nX (11)
The molecular weight of the ion is designated M, and the mass of the charge
carrier, e.g. H+ or Na+, is designated X. The number of charges on a given ion
is designated n, and the m!z value of the peaks in the mass spectrum are
represented by m.
R
R
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Figure 2.39. Molecular weight calculations of b and y ions
To calculate the molecular weight of ions produced by CID MS/MS of the
peptide, a slightly different procedure is used (Figure 2.39). For b1+ ions, the
mass of the charge carrier, X, is zero because the first charge site is the
carbonyl cation, and M is the m/z value itself. For e ions, nX isone because92
the second charge site is generated from protonation of a basic site in the side
chain. The molecular weight of b24- ions is 2m-1. For y ions, because all charge
sites are from protonation of basic sites, X is one. The molecular weights of yl+
and /4- ions are m-1 and 2m-2, respectively. Even for deuterium exchanged
peptides, the mass of charge carrier, X, is not two (D+) but one (W) because all
charge sites are back-exchanged by H20/acetonitrile solvent during HPLC
separation.
The ESI ion-trap mass spectrometer, LCQTM, produced CID spectra that
showed completely different patterns between singly and doubly charged
precursor ions of a peptide 1-12 of Oxi-TRX (Figure 2.40). Singly charged
precursor ions showed increasing peak intensities as the m/z values increased.
The b ions showed greater intensities in fragment ions from the C-terminal side
of a peptide. The y ions showed greater intensities in fragment ions from the N-
terminal side. Doubly charged precursor ions showed greater intensities in the
middle of the spectrum because they are produced by medium-sized b and y
ions. Almost all CID MS/MS experiments of peptic peptides of TRXs were
carried out on the doubly charged precursor ions because doubly charged ions
usually showed greater peak intensities than singly charged ions. Hence, CID
fragment ions possessing extreme m/z values, i.e. too high or too low m/z
values in the MS/MS spectrum, showed very weak signals or no signals at all.
Doubly charged ions of a peptide 1-24 of non-deuterated (0% ref), 20s
deuterated, and fully deuterated (100% ref) Oxi-TRX were used asprecursor
ions for CID MS/MS (Figure 2.41). Reference samples, 0% and 100%,were
used to adjust for deuterium loss during analysis. Reference samples of the
fragment 1-24 of Oxi-TRX indicated that about 15% of the amide deuteriums
were lost during digestion and HPLC and MS analysis. Isotope patterns for the
CID fragment ion, b13, derived from the MS/MS spectrum of the fragment 1-24100
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Figure 2.40. Collision-induced dissociation tandem mass spectrometry
(CID MS/MS) of singly (A) and doubly (B) charged precursor ions of a peptic
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Figure 2.41. CID MS/MS spectra of peptide 1-24 of non-deuterated (A, 0% ref.), 20s labeled (B), fully
deuterated (C, 100% ref.) Oxi-TRX. Right panels represent isotope patterns of the CID fragment, b13.95
of the 0% reference, 20s deuterated, and 100% reference Oxi-TRX samples are
shown in the right side panels. The MS/MS spectra of peptides after H/D
exchange normally show a broad distribution of peaks contributed to by the
naturally occurring isotopes, 13C and 15N. The centroidal mass values were
obtained using MagTran software.51
Some isotopicdistributionsof CID fragments showed overlapped
isotopic multiplets (Figure 2.42). The b12 and y13 ions, whose protonated
masses were 1372.67 and 1377.73,respectively,overlappedafter 20s
deuterium labeling. The deconvoluted multiplets indicated by dashed lines were
used to determine the centroidal mass values. However, in many cases, the
overlapped multiplets could not be resolved when they are very close. This is
one of the reasons why the accurate determination of centroidal value is
difficult.
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Figure 2.42. Overlapped isotopic multiplets of b12 and y13 ions derived
from CID MS/MS spectra of peptic peptide 1-24 of 20s labeled Oxi-TRX.96
Mass values of b and y ions of peptic peptide 1-24 (Figure 2.41) were
summarized and calculated for estimating the deuterium levels at individual
amide linkages (Table 2.5). Calculated m/z values for protonated masses were
used for 0% reference values because these values showed almost the same
m/z values as 0% reference sample and they do not have a missing fragment.
Fragment ion peaks were not found for b11, b14, b16, b21, Y12, and y8.
The molecular weights of CID fragment ions were calculated by the
method mentioned above (Figure 2.39). The number of deuteriums in a CID
fragment ion was calculated by subtracting the protonated mass from the
deuterated mass. These numbers were adjusted for deuterium loss during
analysis according to eq (12).
Adjusted number of deuteriums, A = D x (Q/P) (12)
In the equation, the number of deuteriums in a fragment ion is designated as D,
the number of peptide amide hydrogens is designated as Q, and the deuterium
number on the peptide from fully deuterated sample (100% ref) is designated as
P. In the case for peptide 1-24, the m/z value of the doubly charged precursor
ion from the 100% reference sample was 1312.1, and P is 19.51 as obtained
fromthecalculation,(MWof100%refsample)-(MWof0%ref
sample)=(1312.2x2-2)-2602.89 where 2602.89isthe calculated average
molecular weight of non-deuterated fragment 1-24. The value Q/P is 1.18 from
23/19.51. The adjusted numbers of deuteriums in fragment ions were obtained
by multiplying the number of deuteriums by Q/P. To determine the number of
deuteriums on individual peptide amide linkages, the adjusted number of
deuteriums in a bn_1 ion was subtracted from that in a bn ion.97
Table 2.5. Deuterium levels found at individual amide linkages in peptide 1-24
of Oxi-TRX as determined by CID MS/MS
Ions
(charge)
Protonated
Mass
(calculated)
20s deut.
Mass
(observed)
Number
of D
on ions
Adjusted
number
of D
Number
of D
on residue
residue
NMR b
log kex (s 1)
(1+) b7 807.47 809.3 1.83 2.18 7Leu -4S
b8 908.52 910.41 1.89 2.25 0.1 8Thr -5.01 S
b9 1023.55 1025.6 2.05 2.44 0.2 9Asp -3.11 S
b10 1138.57 1141.51 2.94 3.50 1.1 10Asp -0.21 F
b11 1225.61 (-0.1)a11Ser -3.09S
b12 1372.67 1375.39 2.72 3.24 (-0.1)a12Phe -4.18S
b13 1487.7 1491.58 3.88 4.62 1.4 13Asp cM
b14 1588.75 (0.4)a14Thr -3.24S
b15 1703.78 1708.33 4.55 5.41 (0.4)a15Asp -3.51 S
b16 1816.86 (0.1 )a16Leu -5.4S
b17 1915.93 1920.69 4.76 5.66 (0.1)a17Val -5.93S
(2+) b18 1022.52 1025 4.96 5.90 0.2 18Lys -4.41 S
b19 1058.03 1060.63 5.2 6.19 0.3 19Ala -2.75S
b20 1115.55 1118.49 5.88 7.00 0.8 20Asp cM
b21 1144.06 (0.4)a21Gly -0.21 F
b22 1179.58 1182.83 6.5 7.74 (0.4)a22Ala cM
b23 1236.12 1239.37 6.5 7.74 0.0 231Ie -7.7S
b24 1292.66 1295.78 6.24 7.43 -0.3 24Leu -7.8S
(2+) y22 1200.64 1203.85 6.42 7.64 2.8 3Lys -0.02F
y21 1136.59 1138.62 4.06 4.83 -0.2 41Ie -2.71 S
y20 1080.05 1082.18 4.26 5.07 -1.6 511e -4.06S
y19 1023.51 1026.3 5.58 6.64 1.5 6His -2.6S
(1+) y18 1908.94 1913.22 4.28 5.09 -0.5 7Leu -4S
y17 1795.86 1800.59 4.73 5.63 1.0 8Thr -5.01 S
y16 1694.81 1698.66 3.85 4.58 0.0 9Asp -3.11 S
y15 1579.79 1583.62 3.83 4.56 -0.1 10Asp -0.21 F
y14 1464.76 1468.64 3.88 4.62 1.0 11Ser -3.09S
y13 1377.73 1380.8 3.07 3.65 (0.0)a12Phe -4.18S
y12 1230.66 (0.0)a13Asp cM
y11 1115.63 1118.65 3.02 3.59 0.1 14Thr -3.24S
y10 1014.58 1017.52 2.94 3.50 0.1 15Asp -3.51 S
y9 899.56 902.4 2.84 3.38 (-0.1)a16Leu -5.4S
y8 786.47 (-0.1)a17Val -5.93S
Y7 687.4 690.4 3 3.57 18Lys -4.41 S
a For missing fragment ion, the difference in the number of deuterium is equally
divided. b NMR data were taken from published results.47 C The intermediate
exchange rates are designated as M, which is in the range 0.0025-0.25 s-1 (log
value -2.6 to -0.6).98
For instance, the difference of the adjusted number of ions between the b10 and
b9 ions was 1.1 corresponding to the number of deuteriums incorporated on
peptide amide linkage Asp-10 after 20 s exposure to D20. In case of a missing
fragment ion, the difference of the adjusted number of deuteriums, An+2An,
was equally divided and allotted to the positions n+1 and n+2.
The H/D exchange rate constants of individual peptide amide hydrogens
in Oxi-TRX were taken from previously published NMR data.47 Rapidly
exchanging amide hydrogens designated as F have large exchange rate
constants (kex > 0.25 s-1 or logkex > -0.6). These rate constants were obtained
bysaturation-transfermeasurements.52Veryslowlyexchangingamide
hydrogens are designated as S (kex < 0.0025 s-1 or logkex < -2.6). The amide
protons for which the exchange rate was too slow to measure by saturation
transfer, but which also exchanged too fast to be observed in the H-D
experiments, have intermediate exchange rates and are designated as M,
which is in the range 0.0025 to 0.25 s-1 (log value 2.6 to 0.6).
The relationship between the deuterium levels of each residue and the
exchange rate constants is shown on the graph (Figure 2.43). These results
indicate that deuterium levels at individual peptide amide linkages can be
determined from the m/z of the b ions, although some of the b ion m/z values do
not show perfect matches. The y ions are much less reliable. Some y ions
showed large fluctuations in deuterium content as, for example, Lys-3 (2.8),
His-6 (1.6), and Ile-5(-1.6) which indicates that deuterium incorporation
occurred in the side chain amine sites or deuterium was lost in the peptide
amide linkage. Thr-8, Ser-11, Asp-10, and Asp-13 showed too high or too low
deuterium levels contrary to what would have been expected on the basis of the
NMR data. These results suggest that H/D exchange, i.e. H/D scrambling,
randomly occurs at all possible exchangeable sites of the y ions.(A)1.4
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Figure 2.43. Comparison of b ions (A) and y ions (B) in the deuterium levelson
peptide amide linkages in peptide 1-24 of Oxi-TRX. The H/D exchange rate
constants (NMR data) for the intermediate range (logkex 2.6 to 0.6) were
designated with the average value, -1.6.100
The b ions showed relatively good correlation with NMR data. High
deuterium levels larger than 0.8 were found at Asp-10, Asp-13, and Asp-20
corresponding to large or medium exchange rate constants. Gly-21 and Ala-22
with fast and medium exchange rates, respectively, also showed significantly
higher deuterium levels. However, Thr-14 and Asp-15 have small exchange
rate constants, but unexpectedly showed significant deuterium levels of about
0.4. Asp-13 showed an abnormally high deuterium level of 1.4. There are two
possible reasons for this result. One is that deuterium is incorporated in the side
chain carboxylic acid of Asp-13. The other is that deuterium is lost from the b12
ion. The latter is more probable because the b12 ion had unusually low
deuterium content as shown by the negative deuterium content on Phe-12 and
Ser-11. Although b ions did not show a perfect match with the NMR data, most
of them were in reasonably good agreement with the amount of deuterium
incorporated relative to the rate constants.
These resultsare roughly consistent with CID MS/MS datafor
cytochrome c, in which b ions showed good correlation with the NMR exchange
rate data whereas y ions produced several discrepancies, suggesting that
intramolecular H/D scrambling may occur during CID fragmentation to give the
y ions.31 The apparent high probability for scrambling precludes use of the y
ions for determining deuterium levels at individual amide sites.
The deuterium levels on individual amide sites of fragment 1-24 derived
from Oxi-, Red-, and GS-TRX were determined by analysis of the b ions and
compared with exchange rate constants from NMR data (Figure 2.44 and
Table 2.6 and 3.18). Data for Cys-TRX were not available because the
precursor ion intensity was too weak to carry out CID-MS/MS experiments.
Since only b ions were used to determine the deuterium levels, itwas inevitable
that the H/D exchange information for 5-6 residues at the N-terminal side of this101
peptide were lost. At the N-terminal side of a peptide, b ions are very weak
whereas y ions usually are intense. In this peptide, Oxi-, Red-, and GS-TRX
showed very similar amounts of deuterium. The reduction of the disulfide
linkage in Oxi-TRX had little influence on the exchange rate constants of amide
hydrogens obtained by NMR in this fragment except that Asp-13, Asp-20, and
Ala-22 showed medium rate constants in Oxi-TRX and large rate constants in
Red-TRX. Only one residue, Ala-22, showed the same result by the CID
MS/MS data (Table 2.6). Although Asp-13 and Asp-20 in Red-TRX showed less
deuterium content than Oxi-TRX, those residues still indicated deuterium levels
larger than 0.6. The NMR solution structure of TRX indicated that Asp-10, Asp-
13, Asp-20, Gly-21, and Ala-22 are in turns or loops.22b These five residues
showed high levels of deuterium incorporation in the MS/MS data. Red- and
GS-TRX generally showed good correlation with NMR data especially in the
region that included residues 20-22. They also indicated reasonable data with
no deuterium content greater than 1.0 nor the presence of negative deuterium
content except in the case of Asp-9 in GS-TRX.
Several amide linkages in fragment 1-24 showed very low deuterium
levels for all TRXs. These include Leu-7, Thr-8, Ser-11, Phe-12, Thr-14, Asp-
15, Leu-16, Val-17, Lys-18, Ala-19, Ile-23, and Leu-24 (Figure 2.45). Residues
7-8 are present in the first 1i- strand, and residues 23-24 are in the second 13-
strand. Residues 11-19 are present in the first a-helix. These residues would
thus most likely be strongly hydrogen-bonded and well protected from solvent.
This protection is especially effective for Ile-23 and Leu-24 which are located in
the central strand of the 13-sheet. These residues showed persistent amide
protons in the 15N-1H HSQC NMR spectrum even after 723 hours (one month)
in D20.47102
Table 2.6. Deuterium levels found at individual amide linkages in
fragment 1-24 of Oxi-, Red-, and GS-TRX based on the analysis of b
ions and y ions (in italics) obtained from CID MS/MS.
Residue Number of Ds on residue Log Ic, (s-1)
Oxi-TRX Red-TRX GS-TRX Oxi-TRX Red-TRX
3Lys 2.8 3.9 -0.02F -0.02F
41Ie -0.2 -0.5 -2.71S -2.81S
51Ie -1.6 -0.7 -4.06 S -4.13 S
6His 1.5 0.0-0.6 -2.6 S -2.6S
7Leu -0.5 0.1 -0.6 (0.2) -4 S -4.17 S
8Thr 0.1 1.0 0.00.5 (0.2) -5.01S -5.02 S
9Asp 0.20.0 0.00.0 -0.1 -3.11S-3.28 S
10Asp 1.1 -0.1 0.90.8 0.8 -0.21F 0.12F
11Ser (-0.1)1.0 (0.2)(0.2) 0.0 -3.09 S -3.22 S
12P he (-0.1)(0.0) (0.2)(0.2) 0.0 -4.18 S -4.18 S
13Asp 1.4(0.0) 0.9(0.1) 0.7 a M -0.4F
14Th r (0.4)0.1 0.2 (0.1) 0.1 -3.24 S -3.31S
15Asp (0.4)0.1 0.20.6 0.2 -3.51S -3.49 S
16Leu (0.1)(-0.1) (0.1)(0.2) (0.1) -5.4 S -5.44 S
17Val (0.1)(-0.1) (0.1)(0.2) (0.1) -5.93 S -5.97 S
18Lys 0.2 0.0 (0.3) -4.41S -4.43 S
19Ala 0.3 0.1 (0.3) -2.75 S -2.8 S
20Asp 0.8 0.6 0.8 a M -0.19F
21Gly (0.4) 0.7 (0.9) -0.21F -0.12F
22AIa (0.4) 0.8 (0.9) a M -0.34F
231Ie 0.0 0.2 0.2 -7.7 S -7.6 S
24Leu -0.1 0.1 0.0 -7.8 S -7.8 S
In cases of missing fragment ions, the difference in the number of
deuteriums incorporated was equally divided among the residues and
these are shown in parentheses. The rate constants were classified as
S (slow), M (medium), and F (fast). a The intermediate exchange rates
are designated as M, which is in the range 0.0025-0.25 s-1 (log value
2.6 to -0.6).1.6
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Figure 2.44. Deuterium levels found at peptide amide linkagesin
fragment 1-24 of Oxi-, Red- and GS-TRX.
Figure 2.45. NMR solution structure ofOxi-TRX.22bA fragment including
residues 1-24 is highlighted in blue. The active site is represented in the
ball and stick format, and two cysteine residuesare colored in yellow.104
CID MS/MS spectra of the active site region showed very different
patterns between the TRXs (Figure 2.46 and Table 2.7 and 3.19). Singly
charged precursor ions were used for Oxi- and Red-TRX, and doubly charged
precursor ions were used for GS- and Cys-TRX. In the peptide 28-39 of Oxi-
TRX, only the CID fragment ions that included the disulfide loop were found.
These are b8, b9, b1 0, b11, and b12 ions. CID ions from within the disulfide loop,
b5, b6, and b7, were not found. However, in the fragment 28-37 of Red-TRX, b5
and b6 ions, which were produced from the dissociation occurring between Cys-
32 and Cys-35, were found because the disulfide linkage was reduced. These
data indicate that the disulfide loop structure is too stable to be destroyed by
CID. This observation supports the results of a previous CID MS/MS
experiment in which a peptide that included a cyclic structure was found to be
resistant to CID fragmentation.53 In the fragment 28-37 of GS-TRX, a number of
CID ions were obtained by Glu(E) loss from the attached glutathionyl group.
The numbers of deuteriums at individual amide linkages were calculated
(Table 2.8) using the MS/MS data of 20s labeled TRXs (Table 2.7). There is no
data from Trp-31 to Cys-35 in Oxi-TRX due to the inability to dissociate the
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Figure 2.46(B). CID MS/MS spectra of peptide 28-39 (Oxi-TRX) and
28-37 (Red-, GS- and Cys-TRX) of 20s labeled TRXs.106
resistant disulfide loop. No deuterium was found for Pro-34 because it does not
contain an exchangeable amide hydrogen. NMR data showed a very large
difference in rate constants between Oxi- and Red-TRX at Cys-35, a difference
of more than 5 orders of magnitude.47 This disparity is explained on the basis of
significant structural differences between Oxi- and Red-TRX. Unfortunately,
there is no information forthcoming from MS/MS data to cast further light on the
reasons for the differences in NMR exchange rates because no information was
obtained for Cys-35 in Oxi-TRX.
Table 2.7. The m/z values found in the CID spectra for peptides 28-39 or 28-
37 of non-deuterated and 20 sec deuterated TRXs.
Ions Protonated 20s deut.
(charge)
Mass Mass
(calculated)(observed)
Ions Protonated20s deut.
(charge)
Mass Mass
(calculated)(observed)
(Oxi-TRX, peptide 28-39)
(1+) b3 387.17
b4 573.25
b5
b6
b7
b8
b9
b10
b11
b12
675.25
732.27
829.32
931.32
1059.42
1190.46
1303.54
1374.58
935.03
1063.64
1195.01
1308.22
1379.72
(Red-TRX, peptide 28-37)
(1+) b3 387.17 388.0
b4 573.25
b5
b6
b7
b8
b9
b10
676.26
733.28
830.33
933.34
1061.43
1192.47
678.08
735.81
936.56
1064.83
1196.09
(GS-TRX, peptide 28-37)
(1+)b3 387.17 387.71
b4 573.25 574.22
b5 1009.35 1011.22
b6 1066.38
b7 1163.43
(2+)b8 633.72 635.67
b9 697.77 699.87
b10 763.29 765.52
(Glutamic acid missing ions)
(1+) b5-E 880.35 881.28
b8-E1137.44 1141.38
(2+) y10-E 707.8 709.5
b9-E 633.27 636.58
b8-E 569.22 570.78
(Cys-TRX, peptide 28-37)
(1+)b3 387.17 388.99
b4 573.25 575.8
b5 823.29 826.25
b6 880.31
b7 977.37 981.35
(2+)b8 540.69 543.0
b9 604.74 607.19
b10 670.26 672.92107
Table 2.8. Deuterium levels found at individual amide linkages in peptide
28-39 (Oxi-TRX) and 28-37 (Red-, GS-, and Cys-TRX) of 20s labeled TRXs.
Number of Ds on residue Logkx (s-1)
Residue
Oxi-TRXRed-TRXGS-TRX Cys-TRX Oxi-TRX Red-TRX
31Trp (0.5) 0.5 0.7 -0.55F -0.34F
32Cys (0.5) 0.9 0.4 0.37F aM
33G ly 0.7 (1.0) 1.0 0.14F 1.16F
34Pro
35Cys 0.7 (1.0) 0.6 -5.07 S 0.4F
36Lys 0.6 0.2 0.3 0.3 a M aM
37Met 0.3 0.2 0.3 0.4 a M aM
381Ie 0.1 -4.28 S -2.82S
39AIa 0.5 -3.08 S -2.81S
In cases of missing fragment ions, the difference of deuterium numbers
was equally divided into possible sites as shown in parentheses. a The
intermediate exchange rates are designated as M, which is in the range
0.0025-0.25 s' (log value -2.6 to -0.6).
The only difference between the Oxi- and Red-TRX observed in the
MS/MS data was found at Lys-36. The deuterium level at this residue was
found to be decreased from 0.6 to 0.2 when the disulfide linkage was reduced.
There is no obvious explanation that can be gleaned from the NMR data
because Lys-36 for both Oxi- and Red-TRX showed an intermediate range
exchange rate constant. This decrease is comparable in magnitude with the
Cys-35 exchange rate results which showed an increase of more than 5 orders
of magnitude between Oxi- and Red-TRX.
The alkylation at Cys-32 by glutathionyl and cysteinyl groups generally
resulted in increased deuterium levels for a number of residues close to the
active site. Gly-33 which has an extremely large exchange rate constant in Red-
TRX had even higher deuterium levels in GS- and Cys-TRX when compared to
Red-TRX. The deuterium level of Cys-32 in GS-TRX was expected to be larger
than 1 because this residue has three amide hydrogens including two in the108
glutathionylated side chain. In comparison with Cys-32 in Cys-TRX which has
no amide hydrogens in the cysteinylated side chain, the difference in deuterium
level is 0.5, which can be attributed to the two amide linkages in the glutathionyl
group at Cys-32 of GS-TRX. This level of deuterium, 0.5 (each 0.25 for two
amide linkages in the glutathionyl group) is somewhat low, which means that
the exchange rate constants for these two amide hydrogens in the glutathionyl
group are small. These results suggest that either one or both amide hydrogens
in the glutathionylated side chain at Cys-32 participateinintramolecular
hydrogen bonding. Because these two glutathionyl group amide hydrogens are
located on the surface of the protein, it is assumed that there is no protection
from exposure to the solvent.
CysS/
-32
protein backbone
- - - - - Hydrogen bonding
Figure 2.47. Schematic representation of the glutathionyl group in the
energy minimized geometry calculated for GS-TRX.
Energy minimizedgeometries from AMBER forcefieldconstant
calculations for GS-TRX showed that the Gly NH is hydrogen bonded to the
Cys amide nitrogen, and the amide hydrogen of Cys extends towards the
outside of the molecule (Figure 2.47). From this model, itwas assumed that the109
deuterium level of 0.5 atom resulted from H/D exchange at the central Cys
amide linkage of the glutathionyl group. The exchange rate constant for the Gly
amide hydrogen would then be very small.
The deuterium levels found in peptic peptides including residues 45-58
are summarized (Table 2.9 and 3.20). MS/MS data for Oxi-TRX for this region
were taken from the fragment 45-80 because the precursor ion of fragment 45-
58 of Oxi-TRX was so weak that a number of CID fragment ions were not
found. Residues 48-50 and 53-58 showed relatively low deuterium levels, while
residues 51 and 52 showed high deuterium levels. These results are in fairly
good agreement with NMR rate constant data. Residues 48-50 were present in
the C-terminal side of the second a-helix, Gly-51 and Lys-52 were found in a
turn, and residues 53-58 were found in the third 0-strand from the analysis of
NMR solution structures of TRX (Figure 2.48).22b Gly-51 as well as Gly-21 (in
Figure 2.45) were found in the turn region and showed high deuterium levels
and large exchange rate constants. This is consistent with the small size of
glycine and with its preference for flexible loop and turn regions in the protein.
Leu-53 and Thr-54 of GS- and Cys-TRX showed somewhat greater
levels of deuterium than Oxi- and Red-TRX. This result reflects a marginal
distortion or small opening of the core p-strand. However, there is no obvious
explanation supporting this result because NMR exchange rate data are not
available for the modified TRXs with which to corroborate these results. It is
assumed that these results are not directly related to the changes in the acitive
site because the active site region and alkylated part are remote from the region
that involves residues 45-58 (Figure 2.48). At least,itis observed that the
alkylation at Cys-32 influences the structure of the nearest part as well as
theremote parts of the protein.110
Table 2.9. Deuterium levels found at individual amide linkages in peptide
45-58 of 20s labeled TRXs.
Number of Ds on residue Logkx (s-1)
Residue
Oxi-TRXaRed-TRXGS-TRXCys-TRX Oxi-TRX Red-TRX
48GIu 0.3 0.1 0.1 -4.31S -4.36S
49Tyr 0 -0.2 -0.1 -4.04S -4.03S
50GIn -0.1 0.2 -0.1 -2.85S -2.86S
51Gly 0.8 (0.7)b (0.8)b (0.7)b 0.13F 0.28F
52Lys 0.5 (0.7)b (0.8)b (0.7)b -0.51F -0.19F
53Leu 0 -0.1 0.4 0.4 -4.62S -4.23S
54Thr 0.1 0 0.3 0.4 -6.54S -6.37S
55VaI -0.1 -0.1 0.2 0 -5.1S -5.09S
56AIa 0 0 0.2 0.1 -8.4S -7S
57Lys 0.2 0.1 0.2 0.2 -5.6S -5.66S
58Leu 0.1 0.2 0.1 0.1 -8.2S -7.5S
a Data for Oxi-TRX were taken from a part of the exchange data for
peptide 45-80. b In cases of missing fragment ions, the difference of
deuterium numbers was equally divided into possible sites as shown in
parentheses.
Figure 2.48. NMR solution structure of Oxi-TRX.12b A peptide 45-58 is
highlighted in green. The active site region is represented as ball and
stick, and two cysteine residues are colored in yellow.111
Deuterium levels in the regions that include peptides 59-80 for Oxi- and
Red-TRX and 59-79 for GS- and Cys-TRX were investigated by CID MS/MS
(Table 2.10 and 3.21). The b ions produced from proline amide linkages were
not found because it is very hard to obtain CID fragment ions from this linkage.
Ile-75 showed a significant difference in the number of deuteriums incorporated.
Only GS-TRX showed low deuterium incorporation on Ile-75 whereas Ile-75 of
Red-TRX showed a large exchange rate constant from NMR data and
accordingly, the deuterium content at this amino acid in the Red-TRX was high.
This residue on GS-TRX can be an important clue to explain the interactions
between the glutathionyl group attached at Cys-32 and sites within the protein.
In the structure of Oxi-TRX as determined by NMR, Ile-75 is found to be very
close to the active site region (Figure 2.49). The MS/MS results are very
consistent with what one might expect on the basis of the AMBER force field
calculations for the structure of GS-TRX (Figure 2.50 and 2.51). These
calculations indicated that Ile-75 NH is hydrogen bonded to the ?-Glu carbonyl
of the glutathionyl group.
Because the b13 ion was not observed, the difference in the deuterium
content of b14 and b12 ions were equally divided between Gly-71 and Ile-72
residues. It was assumed that the differences in deuterium numbers between
b14 and b12 ions were derived mainly from Gly-71 because Gly-71 showed
medium and large exchange rate constants for Oxi- and Red-TRX, respectively,
whereas Ile-72 showed small rate constants for both TRXs. Residues Ile-72 in
GS- and Cys-TRX indicated relatively high deuterium levels of about 0.9
deuteriums. This result suggests that there was no protection of the amide
hydrogen in Ile-72 from exchange in GS- and Cys-TRX. Similar resultswere
observed at residues Ala-67 and Thr-66 in Cys-TRX and Asn-63 in GS-TRX.
These residues had relatively high deuterium levels suggesting therewas a loss112
of hydrogen bonding. While one can not entirely exclude H/D scrambling, these
results suggest there may be more far reaching alterations in the regional
conformations of the adducted proteins. The data together in all of these studies
(Table 2.10) indicate that the deuterium level measured at peptide amide sites
is reliable.
Table 2.10. Deuterium levels found at individual amide linkages in
fragments 59-79 (GS- and Cys-TRX) and 59-80 (Oxi- and Red-TRX) of
20s labeled TRXs.
Number of Ds on residuea Log kE, (s"
1) b
Residue
Oxi-TRXRed-TRXGS-TRX Cys-TRX Oxi-TRX Red-TRX
62G1n 0.1 -2.72 S -3.1S
63Asn 0.1 0.5 0.1 -4.8S -4.62 S
64Pro
65Gly 0.6 0.9 0.7 0.9 b M b M
66Thr 0.2 0.2 0.1 0.8 -4.36S -4.15 S
67AIa -0.1 0.2 0.2 0.7 -4.66S -4.54 S
68Pro
69Lys 0.1 0.1 0.3 0.3 -3.21S -3.09 S
70Tyr 0.0 -0.1 0.3 0.2 -5.06 S -4.91S
71Gly (0.3) (0.4) (0.9) (0.9) b M -0.31F
721Ie (0.3) (0.4) (0.9) (0.9) -3.69 S -3.52S
73Arg 0.7 0.7 1.0 1.0 -0.14F -0.2F
74G ly (0.9) 0.8 1.0 1.0 -0.19F 0.23F
7511e (0.9) 0.8 0.1 0.9 b M -0.01F
76Pro
77Thr 0.2 0.3 0.2 0.1 -4.37 S -3.82S
78Leu 0.2 0.3 0.1 0.2 -5.74 S -5.67S
79Leu 0 0.3 0.2 0.1 -7.6S -7.6S
80Leu 0.1 0.2 -8S -8S
a In cases of missing fragment ions, the difference of deuterium numbers
was equally divided into possible sites as shown in parentheses. b The
intermediate exchange rates are designated as M, which is in therange
0.0025-0.25 s'l (log value -2.6 to -0.6).113
Figure 2.49. The NMR solution structure of Oxi-TRX. A region including
residues 59-80 is highlighted in green-yellow. The active site region is
represented inball and stick format, and two cysteine residues are
colored in yellow.
Deuterium levels in the C-terminal regions of 20s-labeled TRXs were
investigated by CID MS/MS in fragments including peptide 81-108 (Table 2.11
and 3.22). For Red-TRX, the peptide 81-101 was used because CID of peptide
81-108 of Red-TRX showed a number of missing ions. NMR data showed that
residues 91-98 had medium or large exchange rate constants. Residues 93-98
consist of a long turn region connecting the fifth 13-strand to the fourth a-helix
(Figure 2.52). Although Thr-89 and Val-91 are present in the fifth 3- strand of
the central 13-sheet, they showed very high deuterium levels. The NMR solution
structure indicated that amide protons of Thr-89 and Val-91 extend toward the
outside of the sheet and are not hydrogen-bonded, so the faster exchange rates114
of these residues are not unexpected.47 Almost all residues showed reasonably
good correlation between CID MS/MS data and the NMR rate constant data.
Table 2.11. Deuterium levels found at individual amide linkages in
fragments 81-108 (Oxi-, GS- and Cys-TRX) and 81-101 (Red-TRX) of
20s labeled TRXs.
Number of Ds on residuea Logkex(s"
1) b
Residue
Oxi-TRX Red-TRX GS-TRX Cys-TRX Oxi-TRX Red-TRX
86VaI 0 0 -0.2 -2.64 S -2.57 S
87AIa -0.1 0 -0.1 0.3 -4.74 S -4.75S
88AIa -0.1 -0.1 (0.3) 0 -4.48 S -4.48S
89Thr 0.6 0.4 (0.3) 0.8 -0.6F -0.24F
90Lys 0 -0.1 (0.8) 0 -3.77 S -3.69S
91Val 0.6 0.4 (0.8) 0.3 b M b M
92GIy 0.6 0.5 (0.3) (0.6) b M -0.02F
93AIa 0.7 (0.7) (0.3) (0.6) -0.59F -0.68F
94Leu 0.9 (0.7) 0.9 0.8 -0.48F -0.11F
95Ser 0.5 0.6 0.7 0.5 b M b M
96Lys 0.8 0.7 0.8 0.9 -0.54F -0.6F
97GIy (1.0) (0.8) 0.9 1.0 b M -0.08F
98GIn (1.0) (0.8) (0.5) 1.1 b M -0.25F
99Leu 0.3 0.2 (0.5) 0.1 -3.74 S -3.84S
100Lys (0.2) -0.1 0.3 (0) -5.18 S -5.14S
101Glu (0.2) 0 0.2 (0) -5.62 S -5.54 S
102Phe 0.1 (0.2) 0.1 -4.26 S -4.28S
103Leu 0.2 (0.2) 0.1 -7.51S -7.47 S
104Asp 0.2 0.1 0 -6.47 S -6.41S
105Ala 0.2 0.2 0.1 -3.94 S -3.8S
106Asn 0.1 0.3 0.2 -4.21S -4.29S
107Leu 0.2 0.6 0.2 -3.55 S -3.35S
108Ala 0.5 1 0.9 b M b M
a In cases of missing fragment ions, the difference of deuterium numbers
was equally divided into possible sites as shown in parentheses. b The
intermediate exchange rates are designated as M, which is in therange
0.0025-0.25 s-1 (log value -2.6 to -0.6).N
Left view Front view Right view
Figure 2.50. Calculated energy-minimized structures of GS-TRX. The glutathionyl group is represented in the ball
and stick format (sulfur in yellow, nitrogen in blue, carbon in grey, oxygen in red). The TRX protein is represented
as ribbons ((x-helices in red, n-sheets in yellow, turns and loops in blue and grey). The structure in the rectangular
box in the right view was magnified and is shown in Figure 2.51.
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Figure 2.51. Schematic representation showing interactions between the adducted glutathionyl group (ball and
stick format; sulfur in yellow, nitrogen in blue, carbon in grey, oxygen in red) and TRX (wire frame). The hydrogen
bonds deduced from the calculated structure are illustrated by dashed lines. rn117
Figure 2.52. The NMR solution structure of Oxi-TRX. A region including
residues 81-108 ishighlightedin yellow-red. The active site regionis
represented in ball and stick format, and the two cysteine residues are
colored in yellow.
In regions where fast H/D exchange would be expected on the basis of
NMR rate constant data, low deuterium content was sometimes observed. The
amides where low levels of deuterium were observed could be sites where
intramolecular interactions occur between the attached group and the protein.
Gly-92 and Ala-93 of GS-TRX and Val-91 of Cys-TRX showed relatively low
deuterium levels despite their large exchange rate constants in this region of
Red-TRX. Moreover, they are located very close to the active site region where
alkylated parts were attached (Figure 2.51). Because the b12 ion derived from
peptide 81-108 of GS-TRX was not found, the difference in the numbers of
deuteriums between b13 and b11 ions, 0.6, was divided equally between Gly-92118
and Ala-93, i.e. 0.3 deuteriums each. From the analysis of the calculated
energy minimized structure of GS-TRX, it was found that Ala-93 NH is hydrogen
bonded to the central Cys carbonyl oxygen of the glutathionyl group attached to
Cys-32 (Figure 2.51). Thus, it is assumed that the difference in the numbers of
deuteriums betweenb13andb11ions, 0.6, is mainly from Gly-92 which has a
large exchange rate constant. In Cys-TRX, Val-91 is responsible for this non-
covalent intramolecular interaction because the deuterium level for Val-91 was
found to be 0.3 in spite of the medium exchange rate constant. This interaction
could result from hydrogen bonding between the carboxylic acid group oxygen
of the cysteinyl group attached to Cys-32 and Val-91 NH.
The deuterium levels and peptide amide exchange rate constants of Oxi-
and Red-TRX were shown with the primary and secondary structure of TRX
(Figure 2.53). The b ions showed generally good correlations with the
exchange rate constants of NMR data. However, this graph shows that CID
MS/MS do not always yield complete sequence information for peptides.
Usually, intermediate size peptide fragment ions are observed but the smaller
ones, i.e.,di-, tripeptides, etc., are sometimes missing. As the size of the
peptides increase, the completeness of the sequence usually diminishes, and
peptides of 30 or more residues almost never yield complete sequence ions.
Some information can in principle be obtained for these ions from thereverse
direction sequences and possibly from other ion series. The total deuterium
content in the stretch of amino acid residues representing the gaps in the
sequence, which often involves no more than two or three residues, will, of
course, be recorded and the average number of deuteriums per residue can be
determined.(A) 1.6
1.4
1.2
1.0
0.8
0.6
0.4
0.2
0.0
-0.2
-0.4
2° structure
(B)
1.0
0.8
0.6
0.4
0.2
0.0
-0.2
-0.4
ttttttttttttt 11111111111111111111 llllllllll 1111111 lllllllllllll 11111111111111111111111111111111111111111111
1 1 : 11 ( I 1 1 11 . TOD STOTDL V N ROG/.
01 a1
IL O O T W O E W C G P C N I .I A P 11 0 EI A 0 E 0 0 0 0 1 1 V A R L N 10 0 1 1P G T A P N YI G R G IP TI L L FONGE VAR 71(00A LINCOLN ET LOANLA
a2 133 a3 04 05 a4
EONI 1111.1.00FO TOL VIRROGA II. EWGOGll P ILO E IRO E VOGNL TRAK LN 10011PG TA PRY IGRG I PTL L LPNNGEVAR TN VGA L IINGOLM ELOAN LA
10 20 30 40 50 60 70 80 90 100
Residues log kex b ions
-2
a)
-3
-4
-5
-6_j
7
-8
9
2
1
0
-1b
-2 Cl)
U)
-3
-4Ym
-503
-6--I0
-7
-8
9
Figure 2.53. The deuterium levels on peptide amide linkages of (A) Oxi-TRX and (B) Red-TRX based on the
analysis of b ions from CID MS/MS spectra and H/D exchange rate constants from NMR data. H/D exchange rate
constants for the intermediate range (logk -2.6 to -0.6) were designated with the average value, -1.6.The secondary
structures are inserted; n- sheets are designated with arrows and a-helices are shown with dotted lines.120
2.3-4 Energy-minimized structure of GS-TRX
The model that was constructed for the GS-TRX places the glutathionyl
group on a broad surface formed by two loop structures in the protein (Figure
2.50 and 2.51). These loops include the broad turn formed by residues 73-77,
and the loop (residues 90 to 93) that connects the fifth p-strand to the fourth a-
helix at the C-terminal end of the protein. The effect of the glutathionyl
modification on the structure of the protein is minimal between the backbone
atomsofthemodifiedandunmodifiedproteins.The most dramatic
conformational change is seen in the rotation of the Arg-73 side chain to form
the salt bridge to the y-Glu of the glutathionyl group.
The resulting model has the two terminal amino acids of the glutathionyl
group forming two salt-bridges to basic side-chains of the protein. The
carboxylate group of the y-Glu residue of the glutathionyl group is oriented
towards the guanidinium group of Arg-73 in the protein, and the carboxy
terminus of the glutathionyl Gly residue towards the amino-side chain of Lys-90
in the protein. This results in a net increase in electrostatic stability of -35 kcal
for the modified over the unmodified protein.
In addition, the gluthathionyl group forms three additional hydrogen
bonding interactions with the amide nitrogens and amide oxygens of the protein
backbone, with the amino terminus of the y-Glu, the y-oxygen of y-Glu, and the
keto oxygen of the Cys residues in the glutathionyl group hydogen bonded to
the keto oxygen of Arg-73, the amide nitrogen of Ile-75 and the amide nitrogen
of Ala-93, respectively, in the peptide backbone of TRX. These hydrogen bonds
are estimated to contribute an additional -11.5 kcal of stabilization to the
modified protein. Interestingly, the loop that includes Gly 74 and Ile 75 adopta
n -sheet type conformation in the protein (with 4 and w -torsion angles ranging121
between -140° and 180°). Thus, the interactions with the y-Glu of the glutathione
extension appear to define a mini-n-sheet at the protein surface. From these
interactions, it was predicted that the amide nitrogens of both Ile-75 and Ala-93
would be protected from solvent by the glutathionyl group and, therefore, would
show a reduction in their rates of H/D exchange.122
2.4 Conclusion
H/D exchange of TRXs in 1% acetic acid was monitored by HPLC-ESIMS.
The difference in stability between Oxi- and Red-TRX was clearly demonstrated
by thermal denaturation and H/D exchange-in experiments. The rate constants of
conversion from folded state to unfolded state were 0.1 and 2.5 min-1 for Oxi- and
Red-TRX, respectively, at 60 °C. H/D exchange time courses showed 7%
difference in deuterium incorporation between Oxi- and Red-TRX. Denaturation
curves derived from the charge state distribution showed that Oxi- and Red-TRX
have about 15 °C difference in the melting temperature. These results were in
close agreement with CD spectral data and comparable to previous NMR data
which showed an enhanced flexibility for Red-TRX in the vicinity of the active
site. From these global H/D exchange experiments, GS-TRX unambiguously
indicated more stabilized structure than Red-TRX. However, Cys-TRX showed
almost the same stability with Red-TRX. These results suggest that the
intramolecular interactions were induced by the attached glutathionyl group in
GS-TRX, and the stabilization by the cysteinyl group attached in Cys-TRX was
negligible.
These differences in global H/D exchange were investigated locally by the
peptic fragmentation/MS approach. Four component analysis of H/D exchange
time courses for each peptide showed dramatic differences in the peptides 28-39
or 28-37. The number of slow exchanging hydrogens changed significantly by the
reduction of the disulfide linkage in Oxi-TRX and alkylations, which suggest
changes in hydrogen bondings and/or conformations in the active site region.
The peptides 59-80 and 81-101 of Oxi- and Red-TRX showed bimodal isotope
patternsindicatingEX1-type mechanism. Thisresult has very important
implications in that even though global H/D exchange showed a stable EX2123
mechanism, localized regions may be governed by the EX1 mechanism.
However, peptides 59-80 and 81-101 of GS- and Cys-TRX followed the EX2
mechanism. These results suggest that in the region 59-108 there may be some
stabilizing effectsin the alkylated TRXs. The peptic fragmentation/ESI-MS
approach was good for localizing H/D exchange results, but it was still not
sufficient to give residue-specific exchange information.
CID MS/MS showed that b ions are useful for determining the extent of
hydrogen exchange at peptide amide linkages in the protein. MS and NMR data
were found to be complementary for determining structural characteristics that
involve the exchange of amide hydrogens. The advantages of using MS are that
the sensitivity is high (nanomolar or picomolar concentrations of proteins and
peptides), large proteins can be analyzed, the time resolution covers a very
broad dynamic range, and correlated hydrogen exchange can be detected.
CID MS/MS results for TRXs showed generally excellent correlations with
H/D exchange rate constants from NMR data. Strong evidence for noncovalent
interactions induced by the glutathionyl group was found at Ile-75 and Ala-93.
These residues have unusually low deuterium levelsin GS-TRX which is
consistent with the expectation from the energy-minimized structure for GS-TRX.
Total stabilization energy, -46.5 kcal/mol, calculated from the energy-minimized
structure of GS-TRX also supports the increased melting temperature and the
reduced rate of conversion of GS-TRX in comparison with Red-TRX.
Although b ions are very useful for determining the deuterium levelson
individual peptide amide linkages, there were uncertainties in the interpretation of
some MS/MS data. First, the missing fragment ions that are attributed to the
inability of CID to fragment specific amide linkagesposes a unique problem since
one cannot determine the level of deuterium at each amide linkage in the
intervening sequence. Second, the overlapped multiplets of b andy ions often124
are unresolved so that an accurate calculation of deuterium levels becomes
difficult. Third, the intensities of CID fragment ions produced from the C- or N-
terminal region in peptides were so weak that it was difficult to obtain well-
resolved mass peaks. Accurate measurements of hydrogen exchange rates at
individual peptide amide linkages would be possible after the mechanism of CID
is better understood.125
CHAPTER 3
EXPERIMENTAL
Chemicals. Recombinant E. co/i thioredoxin (Oxi-TRX) and trypsin were
purchased from Promega (Madison, WI). Glutathione, cysteine, pepsin, and
iodoacetamide were purchased from Sigma (St. Louis, MO). Trifluoroacetic acid,
acetic acid, ammonium bicarbonate, sodium citrate, urea, and formic acid (98%)
were purchased from Fluka (Milwaukee, WI). Tris(2-carboxyethyl)phosphine
hydrochloride (TCEP.HCI) was purchased from Pierce(Rockford,IL).All
deuterated solvents and 1-bromo-2-chloroethane were purchased from Aldrich
(Milwaukee, WI). HPLC grade acetonitrile and methanol were purchased from
Fisher (Pittsburgh, PA). Water was purified by a Milli-Q reagent water system
(Millipore®, Bedford, MA). Protein modification, peptic digestion, and their HPLC
fractionation were performed in 1.5 or 0.6 ml Eppendorf tubes. All liquid samples
were evaporated on a Savant speed-vac concentrator or freeze-dried on
Labconco freeze dry/shell freeze system.
Mass spectrometry. ESI-MS measurements for heat denaturation and
global H/D exchange experiments of TRXs were performed on a Perkin-Elmer
Sciex API III triple quadrupole mass spectrometer (PE-SCIEX, Thornhill, Ontario,
Canada) equipped with a pneumatically assisted electrospray source. Air was
used as the nebulizer gas and nitrogen as curtain gas. The collision gas was a
mixture of nitrogen and argon in a volume ratio of 9 to 1. A Macintosh Quadra 800
computer was used for instrument control, data acquisition, and processing. MS
data for peptide mapping and regiospecific H/D exchange were acquired on a
Finnigan LCQ ion-trap mass spectrometer (Thermo Quest, San Jose, CA)126
equipped with a Finnigan electrospray source and a home-built microspray
source. Xcalibur and MagTran software in IBM PC were used for instrument
control, data acquisition, and data processing.
HPLC. Modified TRXs prepared from large-scale syntheses were purified
with a Vydac (Hesperia, CA) C4 semi-prep or prep HPLC column. For all HPLC-
MS experiments, home-made microbore LC columns were used. For LC
separation of peptic peptides at room temperature, a reverse phase column (100
x 0.32 mm) was packed with C18 (Vydac or LUNA) powder with 5 gm pore size.
For LC separation of peptic peptides at 0 °C, a longer reverse phase column (200
x 0.32 mm) was packed with larger pore size (15 gm) C18 (LUNA) powder. For
HPLC analysis, 0.05% TFA/H20 was used as eluent A and 0.05% TFA/CH3CN as
eluent B. HPLC instrumentation consisted of a Waters (Milford, MA) automated
gradient controller, two Waters 515 HPLC pumps for solvent A and B, and Waters
2487 dual X absorbance detector. For microbore HPLC analysis, a Waters HPLC
system equipped with Rheodyne (Cotati, CA) model 8125 injector and an ABI
Spectroflow 783 programmable absorbance detector was used. A Harvard
Apparatus (South Natick, MA) syringe pump was used to obtain a flow rate of 0.3-
0.5 ml/hr. Fused silica capillary tubing with dimensions of 75 gm i.d. x 145 gm
o.d. or 50 gm i.d. x 148 gm o.d. (Polymicro Technologies, Phoenix, AZ) was used
to couple the liquid effluent to the ESI mass spectrometer.
UV and CD. UV absorption spectra were recorded with a Cary 15
instrument, purged with nitrogen in the far UV region. CD spectra were recorded
on a Jasco J720 spectropolarimeter equipped with a home-built thermoelectrically
controlled cellholder. The CD instrument was calibrated with 0.1% d-10-
camphorsulfonic acid (w/v in deionized water) according to the procedure of Chen
and Yang.54 In UV and CD experiments, a Hellma cylindrical cell with a 0.1 mm or
1 cm path length was used.127
3.1 Alkylation of E. coli thioredoxin and identification of the adducts
3.1-1 Synthesis of alkylating agents
S-(2-Chloroethyl)glutathione (CEG) was synthesized by dissolving 0.1 g (0.32
mmol) of glutathione in 2.5 ml of methanol to which 0.024 g (1.08 mmol) of
sodium was added. The solution was stirred until glutathione was completely
dissolved, and then it was added dropwise to a stirred solution of 0.46 g (3.2
mmol) of 1-bromo-2-chloroethane in 2.5 ml of methanol. The reaction mixture was
stirred for 1 h and then 0.056 ml of acetic acid was added, and the resulting
precipitate was collected by centrifugation. After drying, 95 mg of white solid was
recovered and stored at 4 °C in a desiccator. Reverse-phase HPLC analysis
showed that 70% of the isolated mass was the desired product. The molecular
weight (calc. 369.83) was determined by mass spectrometry, which showed m/z
values of 369.8 and 371.8 whose ratios were consistent with a molecule
containing one chlorine atom. The final product was used for alkylation of the
protein without further purification.
S-(2-Chloroethyl)cysteine (CEC) was synthesized by dissolving 0.1 g (0.825
mmol) of L-cysteine in 2.5 ml of methanol to which 0.06 g (2.5 mmol) of sodium
was added. After cysteine was completely dissolved, the solution was added
dropwise to a stirred solution of 1.2 g (8.3 mmol) of 1-bromo-2-chloroethane in 3
ml of methanol. The reaction was stirred for 1 h, and 0.056 ml of acetic acidwas
added to the solution. The resulting precipitate was collected by centrifugation.
After drying, 80 mg of white product was isolated by the same manner and stored
at 4 °C in a desiccator. HPLC analysis showed that 65% of the isolated masswas
the desired product.128
3.1-2 Reduction and alkylation of E. coil thioredoxin by CEG and CEC
Reduction of thioredoxin. The disulfide linkage of E. coli thioredoxin (200 lig,
0.02 pmol) was reduced by addition of 17 p.Iof 8 mM Tris(2-carboxyethyl)
phosphine hydrochloride (TCEP.HCI) and incubated for 10 min to yield a 1.2 mM
solution of reduced thioredoxin. The reaction was monitored by reverse-phase
HPLC.
Modification of thioredoxin by the episulfonium ion of CEG and CEC.
Aliquots of reduced thioredoxin (17 pl) were mixed with equal volumes of 0.4 M
ammonium bicarbonate buffer (pH 7.7). CEG (265 pg of white solid; actual 184
pg, 0.5 grnol, 25 eq.) was dissolved in 33 pl of 0.4 M ammonium bicarbonate
buffer (pH 7.7) and quickly added to the thioredoxin solution. The pH dropped
slightly with the addition of CEG so that the pH of the reaction mixture was
between 7.0 and 7.4. The reaction was monitored by reverse-phase HPLC. The
reaction mixtures were incubated for 90 min at room temperature. More CEG
(265 pg x 2) was added until the reduced thioredoxin was completely consumed.
(S[2 -(Cys32)ethyliglutathione)thioredoxin (GS-TRX) was isolated by preparative
reverse-phase HPLC on a C4 column (250 x 10 mm, 5 ilm, Vydac, Hesperia,
CA). The elution gradient was linear from 20% B to 40% B in 10 min, then to 50%
B over 15 min, and finally to 70% B in 10 min; the flow rate was 2.5 ml /min.
Solvent A was 0.1% TFA/H20, and solvent B was 0.1% TFA/CH3CN. After freeze-
drying the collected eluent, 144 lig (70%) of GS-TRX was obtained. (S12-
(Cys32)ethyl]cysteine)thioredoxin (Cys-TRX) was prepared from CEC by the same
procedure. After HPLC purification and drying, 160 pg (80%) of Cys-TRX was
obtained.129
3.1-3 Identification of modified sites in the alkylated TRXs by ESI-MS/MS
Tryptic digestion. The freeze-dried GS-TRX (50 gg) was dissolved in 15 gl of
0.4 M ammonium bicarbonate buffer (pH 7.8) and treated with 5 gl of 8 mM TCEP
to minimize dimerization. Free thiols were alkylated by adding 5 gl of 50 mM
iodoacetamide and incubating at room temperature for 10 min. To denature the
protein, 20 gl of 10 M urea (50mM TRIS buffer, pH 8.5) was added. Sequencing
grade trypsin (10 jig) was dissolved in 10 gl of 10 mM HCI, and 2 jig was added
to the sample. The concentration of urea was reduced to about 2 M with the
addition of 45 gl of H2O. The mixture was incubated for 5 h at 37 °C and put into
the freezer until MS analysis.
Peptic digestion. The freeze-dried GS-TRX or Cys-TRX (30 jig) was dissolved in
30 til of 0.1 M citrate buffer (pH 3.0). To denature the protein, 22 gl of 10 M urea
(0.1 M citrate buffer, pH 3.0) was added to the protein solution, which was
incubated for 15 min at room temperature. Pepsin (10 gg) was dissolved in 100 gl
of 5% formic acid and 3.3 gg (33 gl) of pepsin was added to the protein solution.
Digestion was allowed to proceed for 4 h at 37 °C.
HPLC-tandem mass spectrometry. Peptide mapping of the tryptic and peptic
digests was accomplished by reverse phase HPLC on a Vydac C18 column (100 x
1 mm, 5 gm pore size) and Perkin-Elmer Sciex API III plus triple-quadrupole mass
spectrometer (Sciex, Thornhill, Canada). The elution gradient was increased
linearly at a flow rate of 10 gl/min from 10% B to 40% B in 20 min, then to 60% B
over 30 min, and finally to 90% B in 5 min. Solvent A was 0.05% TFA in H2O, and
solvent B was 0.05% TFA in CH3CN. Small aliquots of digests (5 gl) were
introduced via an injector fitted with a 5 gl sample loop. Molecular ions selected by130
the first quadrupole of the mass spectrometer were introduced to dissociate by
colliding them at an energy of 25 eV with argon (2.5 x 1014molecules/cm2) in the
second quadrupole, and the resulting fragment ions were mass analyzed in the
third quadrupole. The ionspray capillary was maintained at 5300 V, and the orifice
voltage was held at 90 V. The doubly charged molecular ion of the peptide 28-37
of GS-TRX had a mass (m/z) 772.4. The masses (m/z) of the CID fragment ions of
precursor ion, m/z 772.4, are summarized with their calculated values (Table3.1).
CID fragment ions of doubly charged precursor ion, m/z 680.0, of peptide 28-37 of
Cys-TRX are summarized (Table 3.2).
Table 3.1. CID fragment ions of peptic peptide 28-37 of GS-TRX
Ions Calculated mass Observed mass
b2 258.12 258.0
b3 387.17 387.2
b5 1009.35 1009.2
y2 278.15 278.4
Y3 381.16 381.2
y4 478.22 478.0
Y5 535.24 535.2
y6 971.35 971.2
y7 1157.43 1157.6
y8 1286.47 1286.8
y9 1357.5 1358.0
y6-E* 842.25 842.0
y7-E* 1028.33 1028.8
y8-E* 1157.37 1158.8
y9-E* 1228.4 1228.4
* CID fragment ions resulted from Glutamic acid (E) loss from
the glutathionyl group attached to Cys-32.131
Table 3.2. CID fragment ions of peptic peptide 28-37 of Cys-TRX
Ions Calculated mass Observed mass
b2 258.12 258.0
b3 387.17 387.2
y4 478.22 478.0
y5 535.24 534.8
y6 785.28 785.2
y7 971.36 972.4
Y8 1100.4 1101.2
Y9 1171.44 1172.8
3.1-4 Sample pretreatment of LC-purified modified TRXs
The theoreticalbasis and experimental details for this section are
described under the heading 'analyses of bimodal charge state distributions'
(chap. 2.2-3 and 3.2-3). Temperature dependent variation of F/(F+U) for GS-TRX
before and after 45 °C equilibration has been summarized (Table 3.3).
Table 3.3. Temperature dependent variation of F/(F+U) for GS-TRX
before and after 45 °C equilibration
Before 45 °C equilibration After 45 °C equilibration
Temp.(°C) F/(F+U) Temp.(°C) F/(F+U)
22 0.81
22 0.465 30 0.825
30 0.505 40 0.815
36 0.55 45 0.8
40 0.66 48 0.745
45 0.73 50 0.69
50 0.63 54 0.58
54 0.49 55 0.51
64 0.41 58 0.45
73 0.385 63 0.42
85 0.37 67 0.39
76 0.4
85 0.38132
3.2 Thermal denaturation of thioredoxin and its derivatives (TRXs)
3.2-1 Online H/D exchange/ESI-MS experiment
Oxi-TRX, GS-TRX, and Cys-TRX (10 j_ig/gl, 0.85 mM) were dissolved in
1% AcOH/H20 (pH 2.6). Red-TRX solution (10 gg/jil, 0.85 mM) was obtained by
dissolving Oxi-TRX in 8 mM TCEP/1% AcOH /H2O. TRX solutions were allowed to
equilibrate for 100 min at 25 °C (equilibration solution). The equilibration solutions
were diluted 50-fold with 1'2/0 AcOD/D20 (labeling solution) at 0 °C. Immediately,
50 III of diluted solution was introduced into a Rheodyne injection valve fitted with
a 40 jil sample loop by pre-cooled syringe. The sample loop (peek tubing i.d. 0.01
in., o.d. 1/16 in., 65 cm) was used as a reaction capillary. The solvent delivery
line, the sample loop, and the injection valve were immersed in a water bath and
equilibrated at the desired temperature between 25 and 80 °C (Figure 2.9). As
soon as the sample was injected into the sample loop, the protein solution in the
sample loop was transferred into the ESI source via a fused silica capillary (i.d.
0.075 mm, 100 cm) which was immersed in an ice water bath to quench H/D
exchange and to facilitate refolding of thermally unfolded TRX. The solvent flow
(0.5 ml/hr) was maintained with a syringe pump and a solvent mixture of 1%
AcOD/D20. MS data were obtained on a PE-Sciex API III triple quadrupole mass
spectrometer. The ionspray voltage was at 4700 V, and the orifice voltage was at
80 V. Data were acquired in the range of m/z 1250 to 1800. The time necessary
for the transport of the protein from the sample loop to the ESI needle was
approximately 60 ± 5 sec. The incubation periods reported represent the time that
the protein sample spent in the sample loop. The time-dependent alteration of
bimodal 8-fold charged molecular ion peak of TRXs at 50, 55, and 60 °C are
summarized (Table 3.4-3.6).133
Table 3.4. Time-dependent changes of bimodal 8-fold charged
molecular ion peak of TRXs in 1% AcOD/D20 at 50 °C
Time (sec) Intensity
f u
f/(f+u)
(Red-TRX)
10 1210300 141730 0.895
40 1029600 248070 0.806
85 947720 375520 0.716
109 801400 388560 0.673
125 584930 402700 0.592
170 573866 470794 0.549
208 510150 565710 0.474
250 356620 587810 0.378
274 306690 508510 0.376
(GS-TRX)
10 228830 24412 0.904
40 243610 34159 0.877
85 227880 62780 0.784
109 224180 82987 0.730
125 238420 85741 0.735
170 189200 92869 0.671
208 189340 109820 0.633
250 140870 90423 0.609
274 98928 60208 0.622
307 52677 40191 0.567
(Cys-TRX)
10 79821 10435 0.884
40 78808 18863 0.807
85 55031 23297 0.703
109 76703 38367 0.667
125 47252 36955 0.561
170 50803 68150 0.427
208 48166 58738 0.451
250 22182 30457 0.421
274 15381 24944 0.381134
Table 3.5. Time-dependent changes of bimodal 8-fold charged
molecular ion peak of TRXs in 1% AcOD/D20 at 55 °C
time (sec) Intensity
f u
f/(f+u)
(Red-TRX)
10 736470 126620 0.853
22 662630 227700 0.744
34 403170 294070 0.578
46 346850 460330 0.430
58 211640 368990 0.365
70 157140 539760 0.225
82 156500 629570 0.199
94 140720 641430 0.180
106 68527 764830 0.082
118 109740 776080 0.124
(GS-TRX)
10 181850 20981 0.897
34 149930 45743 0.766
58 121770 77015 0.613
82 99161 105630 0.484
106 92246 150880 0.379
130 41061 184570 0.182
154 70853 233760 0.233
178 79140 243140 0.246
202 41476 265660 0.135
226 56045 270240 0.172
250 40253 213420 0.159
(Cys-TRX)
10 91362 18744 0.830
22 88977 30682 0.744
34 58809 37760 0.609
46 71775 90715 0.442
61 39715 109260 0.267
70 38957 84301 0.316
82 26688 94627 0.220
94 17542 100940 0.148
106 22461 116230 0.162
118 14700 131100 0.101135
Table 3.6. Time-dependent changes of bimodal 8-fold charged
molecular ion peak of TRXs in 1% AcOD/D20 at 60 °C
Time (sec) Intensity
f u
f/(f+u)
(Oxi-TRX)
43 1538700 196060 0.887
76 1378300 384730 0.782
109 1554800 294770 0.841
142 1375600 614940 0.691
175 1344000 720550 0.651
208 1275100 760220 0.626
241 1081800 598500 0.644
274 778960 457810 0.630
307 473820 403040 0.540
(Red-TRX)
10 350930 66500 0.841
19 543530 227480 0.705
28 352770 410850 0.462
37 107260 512560 0.173
46 83228 592040 0.123
55 78522 588030 0.118
64 96483 633480 0.132
(GS-TRX)
10 149970 26094 0.852
19 129160 41198 0.758
28 100450 64819 0.608
37 71546 83124 0.463
46 53705 88664 0.377
55 36157 137910 0.208
64 23122 164020 0.124136
3.2-2 Offline H/D exchange/ESI-MS experiments
Oxi-TRX, GS-TRX, and Cys-TRX (10 gg/I.1,1, 0.85 mM) were dissolved in
1% AcOH/H20 (pH 2.6). Red-TRX solution (10 jig/p,1, 0.85 mM) was obtained by
dissolving Oxi-TRX in 8 mM TCEP/1% AcOH/H20. TRX solutions were allowed to
equilibrate for 100 min at 25 °C (equilibration solution). H/D exchange was
initiated by diluting the equilibration solution 50-fold with 1% AcOD/D20 at 25 °C
(labeling solution). At each time point, 5 p1 (0.43 nmol) of labeling solution was
introduced into an injection valve fitted with a 5 p1 sample loop by a precooled
syringe. The sovent delivery line, the sample loop, and the injection valve were
immersed in an ice-water bath to minimize H/D exchange of all exchangeable
hydrogens during infusion into the mass spectrometer. The solvent flow (0.3
ml/hr) was maintained with a syringe pump and a solvent mixture of 1%
AcOD/D20. The molecular weight of deuterium labeled TRXs was calculated from
the 7-, 8-, and 9-fold charged molecular ions by using eq (11). The percentage of
deuterium incorporation for Oxi-, Red-, GS-, and Cys-TRX was calculated by eq
(7) (Table 3.7-3.10).137
Table 3.7. Percent deuterium incorporated onto Oxi-TRX after exchange-
in in 1% AcOD/D20 at 25 °C
Time Molecular ions Average
MW
% of D
incorporation* (sec) 7+ ion 8+ ion 9+ ion
0.5 1674.6 1465.7 1303.3 11709.8 20.92
2.5 1675.8 1466.9 1304.3 11718.8 26.09
4 1676.5 1467.4 1304.8 11723.3 28.64
4.5 1676.8 1467.6 1305.0 11725.2 29.74
6 1676.8 1467.8 1305.2 11726.2 30.32
6.5 1677.3 1468.1 1305.4 11728.7 31.75
8.5 1677.7 1468.4 1305.6 11731.3 33.23
9.5 1677.4 1468.3 1305.6 11730.2 32.62
11 1677.8 1468.7 1305.8 11732.5 33.94
12 1677.8 1468.5 1305.7 11732.1 33.71
13 1678.1 1468.7 1306.1 11734.3 34.98
14 1678.1 1468.7 1306.1 11734.5 35.07
15 1678.3 1468.9 1306.1 11735.5 35.65
16 1678.5 1469.1 1306.4 11737.2 36.67
18 1678.3 1468.9 1306.3 11736.0 35.96
33 1679.0 1469.6 1306.8 11740.9 38.78
35 1678.8 1469.4 1306.7 11739.5 37.96
40 1678.9 1469.5 1306.6 11740.0 38.25
60 1679.7 1470.1 1307.3 11745.3 41.27
68 1679.8 1470.2 1307.5 11746.5 41.99
82 1679.8 1470.4 1307.5 11747.0 42.25
98 1680.1 1470.7 1307.8 11749.5 43.71
125 1680.5 1470.9 1307.9 11751.3 44.76
143 1680.7 1471.0 1308.1 11752.6 45.49
175 1681.1 1471.8 1308.1 11755.8 47.35
188 1681.3 1471.8 1308.5 11757.3 48.2
254 1681.6 1472.0 1308.9 11759.5 49.46
* The molecular weight of undeuterated Oxi-TRX is 11,673.4.138
Table 3.8. Percent deuterium incorporated onto Red-TRX after exchange-
in in 1% AcOD/D20 at 25 °C
Time Molecular ions Average
MW
% of D
incorporation* (sec) 7+ ion 8+ ion 9+ ion
0.5 1675.9 1466.5 1303.9 11716.8 23.45
2 1677.4 1467.9 1305.2 11727.8 29.72
3.5 1678.1 1468.9 1305.6 11733.2 32.79
6 1678.6 1469.0 1306.3 11736.7 34.77
8 1678.9 1469.2 1306.4 11738.4 35.72
10 1679.1 1469.6 1306.8 11741.0 37.22
14 1679.7 1470.0 1307.0 11744.5 39.19
18 1680.3 1470.3 1307.0 11746.6 40.36
25 1680.7 1470.7 1307.4 11749.7 42.13
28 1680.5 1470.6 1307.3 11748.7 41.59
31 1680.9 1470.9 1307.6 11750.9 42.83
40 1681.0 1471.0 1308.0 11752.8 43.91
53 1681.2 1471.5 1308.4 11755.9 45.64
65 1681.4 1471.6 1308.9 11758.2 46.97
76 1681.5 1471.7 1309.0 11758.8 47.29
82 1681.9 1472.3 1309.0 11761.4 48.78
98 1682.2 1472.3 1309.2 11762.9 49.66
125 1682.3 1472.6 1309.5 11765.0 50.81
138 1682.8 1472.5 1309.4 11765.3 51.00
155 1682.9 1472.7 1309.7 11767.1 52.00
178 1683.3 1472.9 1309.7 11768.6 52.84
194 1682.8 1473.3 1309.9 11769.2 53.21
250 1683.0 1474.0 1310.0 11771.4 54.45
* The molecular weight of undeuterated Red-TRX is 11,675.5.139
Table 3.9. Percent deuterium incorporated onto GS-TRX after exchange-
in in 1% AcOD/D20 at 25 °C
Time Molecular ions Average
MW
% of D
incorporation* (sec) 7+ ion 8+ ion 9+ ion
0.5 1722.6 1507.9 1340.8 12046.9 21.04
2 1724.0 1509.1 1342.0 12056.8 26.47
4 1724.8 1509.7 1342.4 12061.6 29.12
6 1725.4 1510.1 1342.9 12065.5 31.31
8 1725.7 1510.6 1343.2 12068.5 32.95
12 1726.4 1511.1 1343.6 12072.4 35.12
14 1726.7 1511.0 1343.8 12073.7 35.81
16 1726.9 1511.3 1344.0 12075.7 36.90
18 1727.2 1511.4 1344.2 12077.0 37.63
23 1727.2 1511.8 1344.4 12078.9 38.68
35 1727.6 1511.8 1344.7 12080.4 39.52
45 1728.3 1511.8 1345.1 12083.3 41.12
52 1728.3 1512.0 1345.2 12084.1 41.54
69 1728.5 1512.3 1345.4 12085.9 42.57
76 1728.8 1512.9 1345.8 12089.4 44.52
92 1728.9 1512.9 1345.8 12089.9 44.77
105 1729.2 1513.4 1345.6 12091.0 45.37
115 1729.1 1513.5 1345.7 12091.7 45.77
134 1729.3 1513.6 1345.9 12092.9 46.42
152 1729.6 1513.9 1345.9 12094.7 47.40
172 1730.0 1514.0 1346.0 12096.0 48.14
203 1730.2 1514.2 1346.5 12098.5 49.52
251 1730.3 1514.5 1346.5 12099.4 50.02
* The molecular weight of undeuterated GS-TRX is 12,008.8.140
Table 3.10. Percent deuterium incorporated onto Cys-TRX after exchange-
in in 1% AcOD/D20 at 25 °C
Time Molecular ions Average
MW
% of D
incorporation* (sec) 7+ ion 8+ ion 9+ ion
0.5 1696.1 1484.4 1320.0 11860.2 21.06
2 1697.2 1485.5 1320.9 11868.2 25.58
4 1698.3 1486.2 1321.4 11874.2 28.92
6 1698.7 1486.6 1321.9 11877.6 30.87
8 1698.8 1486.8 1322.3 11879.7 32.03
10 1699.3 1487.3 1322.5 11882.6 33.68
14 1699.6 1487.6 1322.7 11884.9 34.94
18 1700.3 1488.0 1323.2 11889.0 37.24
23 1700.8 1488.4 1323.6 11892.2 39.04
29 1700.9 1488.8 1323.6 11893.8 39.95
45 1701.3 1489.2 1324.3 11897.5 42.04
52 1701.1 1489.3 1324.1 11896.9 41.71
58 1701.2 1489.2 1324.3 11897.4 41.96
75 1701.8 1489.5 1324.8 11901.1 44.03
86 1702.1 1489.4 1324.7 11901.2 44.08
100 1702.9 1489.7 1324.0 11902.0 44.53
105 1702.3 1489.7 1325.0 11903.6 45.48
115 1702.5 1489.9 1325.5 11906.2 46.91
123 1702.8 1490.2 1325.2 11906.5 47.08
144 1702.8 1490.3 1325.3 11907.3 47.53
175 1703.5 1490.6 1325.5 11910.4 49.26
244 1703.7 1490.8 1325.9 11912.5 50.42
* The molecular weight of undeuterated Cys-TRX is 11,822.7.141
3.2-3 Analyses of bimodal charge state distributions
Oxi-TRX, GS-TRX, and Cys-TRX (0.2 gg/111, 0.017 mM) were dissolved in
1% AcOH/H20 (pH 2.6). Red-TRX solution (0.2 gg/RI, 0.017 mM) was obtained by
diluting Red-TRX stock solution (0.85 mM in 8 mM TCEP/1% AcOH/H20) 50-fold
with 1% AcOH/H20. Protein solutions (50 p,I) were introduced into a Rheodyne
injection valve fitted with a 40 ill sample loop. The solvent delivery line, the
sample loop, and the injection valve were immersed in a water bath and
equilibrated at the desired temperature between 25 and 80 °C. After the protein
solutions were incubated for 2 min in the sample loop, they were transferred into
the ESI source. The solvent flow (0.5 ml/hr) was maintained with a syringe pump
and a solvent mixture of 1% AcOH/H20. F/(F+U) was determined as a function of
temperature.
Table 3.11. Temperature dependent variation of F/(F+U) of TRXs in
1% AcOH/H20
Temp
(°C)
F/(F+U)
Oxi-TRX Red-TRX GS-TRX Cys-TRX
30 0.889 0.662 0.815 0.685
40 0.892 0.65 0.831 0.692
45 0.89 0.652 0.812 0.675
50 0.9 0.582 0.79 0.64
53 0.895 0.511 0.728 0.57
56 0.886 0.393 0.619 0.468
60 0.868 0.351 0.46 0.403
65 0.757 0.33 0.395 0.38
68 0.604 0.328 0.4 0.385
72 0.515 0.334 0.39 0.375
76 0.49 0.325 0.405 0.372
80 0.504 0.319 0.41 0.389142
3.2-4 Spectroscopic experiments : UV absorption and circular dichroism
UV spectra of TRXs (34.1 p,M, 1% AcOH/H20) were measured in the near-
UV range (240-350 nm) at 25 °C. Protein solutions were placed in square 1 cm
path length quartz cuvettes. The TRX solution concentration was determined by
using a molar extinction coefficient of 13,700 M-lcm-1 at 280 nm.
Far-UV CD spectra of TRXs (34.1 OA, 10 mM TRIS.HCI, pH 2.5) were
measured in the far-UV range (184-260 nm) in cylindrical 0.1 mm path length
quartz cuvettes and with a bandwidth of 2 nm and a scan speed of 10 nm/min.
Near-UV CD spectra of TRXs (34.1 jiM, 1% AcOH/H20) were measured in
the near-UV range (250-360 nm) in cylindrical 1 cm path length quartz cuvettes.
The temperature control of the sample cell was maintained by circulating water
from a thermostatically controlled water bath through a built-in water jacket sleeve
that is mounted around the CD cell. Temperature readings were measured online
with a thermocouple element glued to the outside of the cuvette wall. Cuvettes
were allowed a 5-min equilibration period after reaching the desired operating
temperature before scanning. The temperature was manually increased from 25
to 80 °C. Equilibrium thermal denaturation of TRXs was monitored at 280 nm. All
spectra were smoothed with software provided with the instrument and base line-
corrected for the CD signal in the absence of protein.
The mean residue molar ellipticity[O]kat a given wavelength was
calculated according to eq (13):
(MW In)9,1
[19l2=
100[111
(13)143
where OA, is the observed ellipticity in degrees, MW is the molecular weight of
TRXs, n is the number of residues (n = 108), [P] is the protein concentration in
mol dm-3, and / is the path length in centimeters. The thermal denaturation of
TRXs was observed by near UV-CD experiments (Table 3.12).
Table 3.12. Temperature dependent variation of the mean residue
molar ellipticity at 280 nm, [O]2m of TRXs in 1% AcOH/H20
Temp. [8]280 x 10 -2
(°C) Oxi-TRX Red-TRX GS-TRX Cys-TRX
25 2.158 1.733 1.158 1.059
30 2.054 1.574 1.076 0.950
34 1.402 1.001 0.869
38 1.767 1.183 0.932 0.821
43 1.701 0.604 0.854 0.728
48 1.621 0.169 0.677 0.422
53 1.446 0.032 0.232 -0.064
57 1.144 -0.038 -0.200
61 0.544 -0.143 -0.239 -0.309
65 -0.022 -0.278
68 -0.235 -0.340 -0.348
72 -0.369 -0.334
76 -0.397 -144
3.3 Structural features of TRXs analyzed by H/D exchange
3.3-1 Peptide mapping and sequencing of TRXs
Oxi-TRX, GS-TRX, and Cys-TRX (1 µg /µl, 85 gM) were dissolved in 1%
AcOH/H20 (pH 2.6). Red-TRX solution(1gg/gl, 85 p,M) was obtained by
dissolving Oxi-TRX in 8 mM TCEP/1% AcOH/H20. Pepsin solution was prepared
by dissolving pepsin (3 gg/g1) in 5% formic acid. The solution was stored at 0 °C
until used. TRX was digested by mixing 5 gl (5 lig) of protein solution with 1 gl (3
lig) of pepsin solution and incubating for 5 min at 0 °C. For the peptic digests, 5 gl
of digest was loaded onto a C18 column (Vydac, 100 x 0.32 mm, 5 gm). The
Rheodyne injector, column, and transfer line were immersed in an ice bath (0 °C)
for low-temperature separation. The resulting peptides were separated in 10 min
with a 25-70% acetonitrile/water gradient system. MS and MS/MS data were
obtained with a Finnigan LCQ mass spectrometer. CID MS/MS data were used
for identifying the peptic peptides. The observed CID fragment ions for eight
major peptic peptides of TRXs are shown below (Table 3.13)
Table 3.13. Observed fragment ions in CID MS/MS spectra of peptic peptides
from the digestions of TRXs
Peptide
(residues)
Observed Fragment Ions
P6 (1-12)
1372.6 (b12), 1225.5 (b11), 1188.6 (y10),1138.5 (b10),
1060.6 (y9), 1023.5 (b9), 947.4 (y8), 908.5(b8), 834.3 (y7),
807.4 (b7), 694.5 (b6)145
Table 3.13 (Continued)
P15 (1-24)
1916.8 (b17), 1908.9 (y18), 1703.5 (b15), 1579.5 (y15),
1487.5 (b13), 1464.6 (y14), 1372.5 (b12), 1292.8(b24+2)
1236.2 (b23+2), 1179.6 (b22+2), 1115.4 (b20+2), 1058.1(b19+2)
1023.3 (b9), 899.4 (y17+2), 807.3 (b7), 687.2 (b12+2)
557.2 (b5), 444.3 (b4)
P17 (28-39) 1374.5 (b12), 1303.4 (b11), 1190.4 (b10), 1172.4 (b10-H20)
Oxi-TRX 1135.4 (y10), 1059.4 (b9), 1006.4 (y9)
P18 (28-37)
GS-TRX
1286.5 (y8), 1157.6 (y7), 1137.6 (b8-E), 1028.4 (y7-E),
1009.7 (b5), 842.5 (y6-E), 763.3 (ble), 707.8 (y10+2-E),
699.0 (b10+2-E), 697.5 (b9+2), 633.9(b8+2)
P18 (28-37)
Cys-TRX
977.6 (b7), 823.3 (b5), 670.3(b10+2),604. 7 (b9+2),
574.0 (b4), 540.8 (b8+2), 387.7 (b3)
P5 (45-58)
1530.7 (b14), 1417.6 (b13), 1364.7 (y12), 1289.6 (b12),
1249.7 (y11), 1218.6 (b11), 1120.6 (y10), 1119.6 (b10),
1018.5 (b9), 957.6 (y9), 905.4 (b8), 829.5 (y8), 777.4 (b7),
720.3 (b6), 592.2 (b5)
P16 (59-80)
1881.0 (y18), 1797.9 (b17), 1767.8 (y17), 1626.9 (b15),
1613.9 (y15), 1512.9 (y14), 1470.0 (b14), 1412.5 (b13),
1441.9 (a14), 1440.8 (y13), 1215.7 (y11), 1168.4 (b22+2),
1120.0 (y21+2), 1111.3 (b21+2), 1063.4 (y20+2), 1054.8 (b20+2),
1005.8 (y19+2), 997.6 (b19+2), 947.8 (b18+2), 941.5 (y18+2),
911.5 (b9), 882.6 (y8),740.4 (b7), 585.3 (b5), 556.2 (y5),
359.4 (y3)
P13 (81-108)
1899.8 (b19), 1874.7 (y18), 1774.6 (y17), 1786.7 (b18),
1758.7 (a18), 1717.6 (y16), 1716.0 (y16), 1658.8 (b17),
1647.7 (y15), 1601.5 (b16), 1533.6 (y14), 1473.7 (b15),
1452.2 (b28+2),1446.6 (y13), 1416.5 (b27+2), 1407.5 (b26+2), 1386.6 (b14),
1318.4(y12), 1302.7 (b25+2), 1273.5 (b13), 1266.9 (b24+2), 1262.4 (y11),
1209.9(b23+2), 1203.0 (b12), 1152.9 (b22+2), 1145.6 (b11), 1133.6 (y10),
1079.2 (b21+2), 1046.3 (b10), 1020.8 (y9), 918.4 (b9), 817.4 (b8),
746.3 (b7), 675.4 (b6)146
3.3-2 H/D exchange of TRXs, proteolysis, and the determination of thedeuterium
content of peptide segments
Oxi-TRX, GS-TRX, and Cys-TRX (10 lig/gl, 0.85 mM) were dissolved in
1% AcOH/H20 (pH 2.6). Red-TRX solution (10 gg/gl, 0.85 mM) was obtainedby
dissolving Oxi-TRX in 8 mM TCEP/1% AcOH/H20. Deuterium exchange was
initiated by diluting the protein solution 20-fold with 1% AcOD/D20. Solutions
were maintained at room temperature and allowed toexchange for various
lengths of time. At appropriate intervals, aliquots (10 RI, 430 pmole) of diluted
solution were taken and cooled to 0 °C. Immediately after quenching, exchanged
TRXs in aliquots were digested by adding 1 pl of pepsin solution (3 pg/p,1 in 5%
formic acid) for 5 min. Aliquots (5 111) were taken from the digest and loaded onto
a microbore HPLC column in an ice bath. The pepticpeptides were separated in
10 min with a 25-70% acetonitrile/water gradient containing 0.05% trifluoroacetic
acid. The column effluent (10 µl /min) was delivered directly to the PE-Sciex API III
triple quadrupole mass spectrometer. The deuterium levels of peptic peptides of
TRXs are summarized (Table 3.14.- 3.17). When there are two molecular ions
with different charge states, an average deuterium level was calculated.
A quantitative interpretation of these results was obtained by conversion of
time course data into rate data. Nonlinear curve fitting was performed by using a
program of Microcal Origin (Microcal software, Northampton, MA).147
Table 3.14. Deuterium levels of peptic peptides of Oxi-TRX in H/D exchange-
in experiments in 1% AcOD/D20
PeptideTime
(min)
m/z D
level
Peptide Time
(min)
m/z D
level
1-12 0 696.0(+2) 13-24 0 616.0(+2)
0.5 698.8 5.6 0.5 616.6 1.2
1 699.1 6.2 1 618.4 4.8
3 699.4 6.8 3 618.4 4.8
10 699.4 6.8 10 617.5 5.6
30 700.0 7.5 30 619.9 7.2
60 699.7 7.4 60 619.1 7.5
120 700.0 8 120 620.5 8.5
180 699.7 8 180 619.6 8.4
28-39 0 697.0(+2) 45-58 0 775.3(+2)
0.5 697.6 1.2 0.5 777.7 4.8
1 698.2 2.4 1 778.0 5.4
3 699.1 4.2 3 778.9 7.2
10 699.4 4.8 10 780.1 9.2
30 700.9 6.2 30 780.7 10.2
60 700.6 7.2 60 780.4 10.8
120 700.6 7.2 120 781.0 11.4
180 700.9 7.8 180 780.7 11.2148
Table 3.15. Deuterium levelsof peptic peptides of Red-TRX inH/D
exchange-in experiments in 1% AcOD/D20
PeptideTime m/z D PeptideTime m/z
(min) level (min) level
1-12 0 696.0(+2) 13-24 0 616.0(+2)
0.5 698.5 5 0.5 617.2 2.4
1 699.5 7 1 617.6 3.2
3 699.7 7.4 3 618.1 4.2
10 700 8 10 619.1 6.2
30 700.1 8.2 30 619.4 6.8
60 700.3 8.6 60 619.7 7.4
120 700 8.4 120 620.1 8.2
180 700 8.8 180 620 8
28-39 0 698.2(+2)
0.5 698.8 2.5
1 699.5 3.6
3 699.9 4.4
10 700.5 5.6
30 700.9 7.8
60 701.2 8.2
120 701.5 8
180 701.6 8.4
PeptideTime m/z D m/z D Average
(min) level level D level
45-58 0 775.3(+2) 517.0(+3)
0.5 776.5 2.4 518.2 3.6 3
1 776.9 3.2 518.5 4.5 3.85
3 778.3 6 518.8 5.4 5.7
10 779.5 8.4 519.1 6.3 7.35
30 780.8 11 520 9 10
60 780.7 10.8 520.5 10.5 10.65
120 780.7 10.8 520.6 10.8 10.8
180 781 11.4 521.2 12.6 12149
Table 3.16. Deuterium levels of peptic peptides of GS-TRX in H/D
exchange-in experiments in 1% AcOD/D20
PeptideTime (min) m/z D level
28-37 0 772.4 (2+)
0.5 773.3 1.8
1 774.2 3.6
3 774.2 3.6
10 774.5 4.2
30 775 5.2
60 775.1 5.4
120 775.5 6.2
180 775.4 6
PeptideTime (min) m/z D level m/z D level Average
D level
1-12 0 695.9 (2+) 1390.7 (1+)
0.5 698.6 5.4 1397 6.3 5.85
1 698.9 6 1397 6.3 6.15
3 699.8 7.8 1397.9 7.2 7.5
10 699.8 7.8 1398.8 8.1 7.95
30 700.1 8.4 1399.1 8.4 8.4
60 700.1 8.4 1399.4 8.7 8.55
120 700.1 8.4 1399.1 8.4 8.4
180 700.1 8.4 1400 9.3 8.85
13-24 0 615.8 (2+) 1230.8 (1+)
0.5 617 2.4 1233.2 2.4 2.4
1 617.3 3 1233.8 3 3
3 617.6 3.6 1234.4 3.6 3.6
10 618.2 4.8 1235.6 4.8 4.8
30 618.8 6 1237.1 6.3 6.15
60 618.8 6 1237.7 6.9 6.45
120 619.4 7.2 1238 7.2 7.2
180 619.4 7.2 1238 7.2 7.2
45-58 0 517.1 (3+) 775.1 (2+)
0.5 518.6 4.5 776.9 3.6 4.05
1 518.3 3.6 777.2 4.2 3.9
3 519.5 7.2 779.3 8.4 7.8
10 520.4 9.9 780.2 10.2 10.05
30 520.7 10.8 780.5 10.8 10.8
60 521 11.7 780.8 11.4 11.55
120 520.7 10.8 780.8 11.4 11.1
180 521.3 12.6 781.1 12 12.3150
Table 3.16 (Continued)
PeptideTime (min) m/z D level m/z D levelD level (Ave.)
59-80 0 784.7 (3+) 1176.5 (2+)
0.5 786.8 6.3 1179.8 6.6 6.45
1 787.1 7.2 1180.4 7.8 7.5
3 788.3 10.8 1182.6 12.2 11.5
10 789.2 13.5 1183.7 14.4 13.95
30 789.8 15.3 1184.6 16.2 15.75
60 789.8 15.3 1184.3 15.6 15.45
120 789.8 15.3 1184.3 15.6 15.45
180 790.1 16.2 1184.6 16.2 16.2
81-101 0 725.9 (3+) 1088.6 (2+)
0.5 727.8 5.7 1091.3 5.4 5.55
1 728.6 8.1 1092.5 7.8 7.95
3 730.7 14.4 1095.2 13.2 13.8
10 731.3 16.2 1096.4 15.6 15.9
30 731.9 18 1097 16.8 17.4
60 731.9 18 1097.3 17.4 17.7
120 731.6 17.1 1097.3 17.4 17.25
180 731.6 17.1 1097.3 17.4 17.25
Table 3.17. Deuterium levels of peptic peptides of Cys-TRX in H/D
exchange-in experiments in 1% AcOD/D20
PeptideTime (min) m/z D level
28-37 679.4 (2+)
0.5 680.3 1.8
1 680.9 3
3 681 3.2
10 681.2 3.6
30 681.2 3.6
60 681.6 4.4
120 681.6 4.4
180 681.8 4.8
PeptideTime (min) m/z D level m/z D levelD level (Ave.)
1-12 695.9 (2+) 1391 (1+)
0.5 698.3 4.8 1395.8 4.8 4.8
1 699.2 6.6 1397.6 6.6 6.6
3 699.8 7.8 1398.8 7.8 7.8
10 700.1 8.4 1398.8 7.8 8.1
30 700.1 8.4 1399.1 8.1 8.25
60 700.1 8.4 1399.4 8.4 8.4
120 700.1 8.4 1399.4 8.4 8.4
180 700.2 8.6 1400 9 8.8151
Table 3.17 (Continued)
PeptideTime (min) m/z D level m/z D level Average
D level
13-24 616.1(2+) 1230.8(1+)
0.5 616.7 1.2 1232.9 2.1 1.65
1 617.2 2.2 1232.9 2.1 2.15
3 617.6 3 1233.8 3 3
10 618.2 4.2 1235.6 4.8 4.5
30 618.5 4.8 1236.8 6 5.4
60 619.4 6.6 1237.1 6.3 6.45
120 619.4 6.6 1237.7 6.9 6.75
180 619.4 6.6 1238.3 7.5 7.05
45-58 517.1(3+) 775.1(2+)
0.5 518 2.7 776.6 3 2.85
1 518.6 4.5 777.2 4.2 4.35
3 519.6 7.5 778.7 7.2 7.35
10 520.2 9.3 779.8 9.4 9.35
30 520.5 10.2 780.5 10.8 10.5
60 520.7 10.8 780.8 11.4 11.1
120 520.7 10.8 780.8 11.4 11.1
180 520.9 11.4 780.8 11.4 11.4
59-80 784.7(3+) 1176.5(2+)
0.5 786.2 4.5 1179.5 6 5.25
1 787.1 7.2 1180.7 8.4 7.8
3 788.6 11.7 1182.1 11.2 11.45
10 789.2 13.5 1183.7 14.4 13.95
30 789.8 15.3 1184.6 16.2 15.75
60 789.8 15.3 1184.6 16.2 15.75
120 789.8 15.3 1184.3 15.6 15.45
180 789.8 15.3 1184.7 16.4 15.85
81-101 725.9(3+) 1088.6(2+)
0.5 727.4 4.5 1091.3 5.4 4.95
1 728.9 9 1093.1 9 9
3 729.8 11.7 1094.9 12.6 12.15
10 731 15.3 1096.4 15.6 15.45
30 731.6 17.1 1097.3 17.4 17.25
60 731.9 18 1097.3 17.4 17.7
120 731.9 18 1097.3 17.4 17.7
180 731.6 17.1 1097.3 17.4 17.25152
3.3-3 H/D exchange of TRXs, proteolysis, and tandem mass spectrometry for
residue-specific hydrogen exchange
Oxi-TRX, GS-TRX, and Cys-TRX (10 lig/gl, 0.85 mM) were dissolved in
phosphate buffer (10 mM, pH 5.7). Red-TRX solution (10 lig/gl, 0.85 mM) was
obtained by dissolving Oxi-TRX in 8 mM TCEP/phosphate buffer (10 mM, pH
5.7). Deuterium exchange was initiated by diluting 1p.1 of protein solution with 20
p1 of 10 mM phosphate buffer (D20). Solutions were maintained at room
temperature and allowed to exchange for 20 sec. Aliquots (5 111, 200 pmole) of
diluted solution were adjusted to pH 2.5 by the addition of 0.1M HCI and cooled to
0 °C. Immediately after quenching, exchanged TRX aliquots were digested by
adding 11..t1 of pepsin solution (3 jig/111 in 5% formic acid) for 5 min. Aliquots (5 RI)
were taken from the digest and loaded onto a microbore HPLC column in an ice
bath. The peptic peptides were separated over a 10 min period with a 25-70%
acetonitrile/water gradient containing 0.05% trifluoroacetic acid. The column
effluent (30 µl /min) was delivered directly to a Finnigan LCQ ion-trap mass
spectrometer for ESI-MS and ESI-MS/MS experiments. The observed CID
fragment ions for major peptic peptides of 20 sec deuterium labeled TRXs are
summarized below (Table 3.18-3.22). The TRX protein models (Figure 2.45,
2.48, 2.49, and 2.52) were constructed by the software RasMol (v. 2.7.1) 55 based
on the structure downloaded from the Protein Data Bank (PDB code : 1X0A).
3.3-4 Structural calculations of GS-TRX
The construction of a model for the GS-TRX was started with the 2.2 A
resolution single-crystal structure of E. coli thioredoxin which was downloaded
from the Protein Data Bank (PDB code : 1TXX).56 The disulfide bond between153
the 13-sulfurs of Cys A32 and Cys A35 was broken, and a hydrogen added to the
A35 residue. All subsequent molecular mechanical simulations were performed
using the AMBER force-field as implemented in the Discover module of the
program Insight II (Biosym/MSI, San Diego, CA). The entire protein structure
was subjected to energy minimization to relieve strain in the starting model. The
glutathionyl group was constructed with the amino acids in their extended
conformations off the sulfur of Cys-32 using the Biopolymer module of the Insight
II program. With the atoms of the protein fixed, the glutathionylchain was
subjected to a systematic set of rigid rotations about the four bonds of the
ethylenelink between Cys-32 and the Cys residueof theglutathionyl
modification. This search resulted in four classes of rotamer conformations with
no major collisions near the site of attachment. The glutathionyl-chain in each of
these four rotamers were then subjected to a series of molecular dynamics
simulations and energy minimizations, again with the atoms of the protein fixed,
to adapt each rotamer of the glutathionyl-chain to the protein structure.Finally,
the overall structure of the glutathionyl-modified proteins were subjected to
molecular dynamics at low temperature (300K), and energy minimized.The
structure having the lowest overall potential energy was defined as the GS-TRX
model.154
Table 3.18. CID fragment ions of peptic peptide 1-24 of TRXs after an incubation
in 10 mM phosphate buffer (D20) for 20 sec
CID ion
(charge state)
Protonated Observed mass ( m/z)
Mass (cal.) Oxi-TRX Red-TRX GS-TRX
(1+)b5 557.33 558.34
b6 694.39 695.43 696.94
b7 807.47 809.3 808.59
b8 908.52 910.41 909.66 911.45
b9 1023.55 1025.6 1024.72 1026.39
b10 1138.57 1141.51 1140.45 1142.25
b11 1225.61 1229.31
b12 1372.67 1375.39 1374.9 1376.41
b13 1487.7 1491.58 1490.65 1492.18
b14 1588.75 1591.83 1593.36
b15 1703.78 1708.33 1707.01 1708.55
b16 1816.86
b17 1915.93 1920.69 1919.36 1920.94
(2+)b18 1022.52 1025 1024.25
b19 1058.03 1060.63 1059.8 1060.85
b20 1115.55 1118.49 1117.55 1118.77
b21 1144.06 1146.34
b22 1179.58 1182.83 1182.16 1183.73
b23 1236.12 1239.37 1238.77 1240.36
b24 1292.66 1295.88 1295.35 1296.9
Table 3.19. CID fragment ions of peptides 28-39 or 28-37 of TRXs after an
incubation in 10 mM phosphate buffer (D20) for 20 sec
Ion Oxi-TRX Red-TRX GS-TRX Cys-TRX
Ca lc. ObservedCaic.ObservedCa lc.ObservedCaic.Observed
b3 387.17 387.17 388.0 387.17 387.71 387.17388.99
b4 573.25 573.25 573.25574.22573.25 575.8
b5 675.25 676.26 678.08 1009.41011.2823.29 826.25
b6 732.27 733.28 735.81 1066.4 880.31
b7 829.32 830.33 1163.4 977.37981.35
b8 931.32 935.03 933.34936.56633.72 635.67540.69 543
b9 1059.421063.641061.431064.83697.77699.87604.74607.19
b101190.461195.011192.471196.09763.29765.52 670.26 672.92
b111303.541308.22
b121374.581379.72155
Table 3.20. CID fragment ions of peptic peptide 45-58 of TRXs after an
incubation in 10 mM phosphate buffer (D20) for 20 sec.
CID Oxi-TRX CID
Ion
Protonated Observed mass (m/z)
Ion Ca lc. Observed Mass (calc)Red-TRXGS-TRXCys-TRX
(1+) b6
b7
b8
b9
b10
b11
b12
b13
b14
720.32
777.34
905.44
1018.52
1119.57
1218.64
1289.67
1417.77
1530.85
721.42
779.27
907.87
1020.95
1122.05
1221.07
1292.1
1420.4
1533.58
(1+)
(2+)
b3
b4
b5
b6
b7
b8
b9
b10
b11
b12
b13
b14
300.16
429.2
592.26
720.32
777.34
905.44
1018.52
1119.57
1218.64
1289.67
709.39
765.93
301.8
429.73
592.78
721.19
907.08
1020.07
1122.34
1221.02
1291.97
710.64
767.55
300.94
430.04
592.96
721.17
907.67
1021.1
1122.4
1221.68
1292.91
711.08
767.68
301.37
430.5
593.5
721.48
907.86
1021.31
1122.72
1221.83
1292.95
711.1
767.7
Table 3.21. CID fragment ions of peptic peptide 59-79 or 59-80 of TRXs
after an incubation in 10 mM phosphate buffer (D20) for 20 sec.
CID
ion
Protonated Observed mass (m/z)
Mass (caic) Oxi-TRX Red-TRX GS-TRX Cys-TRX
(1+)b4
b5
b6
b7
b8
b9
471.22
585.26
682.32
739.34
840.39
911.42
587.5
742.14
843.36
914.3
473.02
587.18
742.2
843.5
914.74
475.27
589.83
687
744.72
845.83
917.05
474.37
588.5
685.62
743.52
845.4
b10 1008.48 1014.15
b11 1136.57 1139.57 1140 1142.57
b12 1299.63 1302.59 1302.97 1305.92 1305.81
b13 1412.72
b14 1469.74 1473.23 1473.92 1477.89 1477.79
b15 1625.84 1630 1630.72 1635.01 1634.93
b16 1682.86 1688.55 1693.02 1692.98
b17 1795.95 1801.87 1802.45
(2+)b17 898.48 903.61 904
b18 947 950 952.55
b19 997.53 1000.62 1000.95 1002.75 1003.15
b20 1054.07 1057.26 1057.66 1059.36 1059.8
b21 1110.61 1113.8 1114.36 1116.02 1116.4
b22 1167.15 1170.39 1171.01156
Table 3.22. CID fragment ions of peptic peptide 81-101 or 81-108 of TRXs
after an incubation in 10 mM phosphate buffer (D20) for 20 sec.
CID
ion
Protonated Observed mass (m/z)
Mass (calc) Oxi-TRX Red-TRX GS-TRX Cys-TRX
(1+)b5 576.28 577.8 579.22 577.99
b6 675.35 676.85 678.31 676.58 676.9
b7 746.38 747.82 749.31 747.5 748.2
b8 817.42 818.78 820.25 819.2
b9 918.47 920.31 921.7 920.22 920.96
b10 1046.56 1048.4 1049.7 1049.05
b11 1145.63 1147.95 1149.14 1148.8 1148.45
b12 1202.65 1205.5 1206.66
b13 1273.69 1277.14 1277.39 1277.7
b14 1386.77 1391 1392.18 1391.3 1391.49
b15 1473.81 1478.44 1479.8 1479 1479
b16 1601.9 1607.22 1608.6 1607.83 1607.98
b17 1658.92 1665.66 1665.94
b18 1786.98 1794.08 1795
(2+)b18 893.99 898.1
(2+)b19 950.54 954.73
(1+)b19 1900.07 1907.43 1907.71 1908.21
(2+)b20 1014.58 1018.73 1018.54
b21 1079.11 1082.95 1083.27 1083.15 1083.2
b22 1152.64 1156.54 1156.77
b23 1209.18 1213.18 1213.38 1213.35
b24 1266.7 1270.77 1270.96 1270.88
b25 1302.21 1306.37 1306.58 1306.42
b26 1359.24 1363.46 1363.76 1363.53
b27 1415.78 1420.1 1420.6 1420.18
b28 1451.3 1455.84 1456.58 1456.12157
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